<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">30916</article-id><article-id pub-id-type="doi">10.7554/eLife.30916</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Computer-guided design of optimal microbial consortia for immune system modulation</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-94085"><name><surname>Stein</surname><given-names>Richard R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5110-6863</contrib-id><email>stein@jimmy.harvard.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-103616"><name><surname>Tanoue</surname><given-names>Takeshi</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-103617"><name><surname>Szabady</surname><given-names>Rose L</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-103618"><name><surname>Bhattarai</surname><given-names>Shakti K</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-103619"><name><surname>Olle</surname><given-names>Bernat</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-103620"><name><surname>Norman</surname><given-names>Jason M</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-103621"><name><surname>Suda</surname><given-names>Wataru</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-103622"><name><surname>Oshima</surname><given-names>Kenshiro</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-103623"><name><surname>Hattori</surname><given-names>Masahira</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-86497"><name><surname>Gerber</surname><given-names>Georg K</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9149-5509</contrib-id><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-40152"><name><surname>Sander</surname><given-names>Chris</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-103624"><name><surname>Honda</surname><given-names>Kenya</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" corresp="yes" id="author-103625"><name><surname>Bucci</surname><given-names>Vanni</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3257-2922</contrib-id><email>vanni.bucci@umassd.edu</email><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf8"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">cBio Center, Department of Biostatistics and Computational Biology</institution><institution>Dana-Farber Cancer Institute</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Biostatistics</institution><institution>Harvard T.H. Chan School of Public Health</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Department of Systems Biology</institution><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Broad Institute of MIT and Harvard</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>RIKEN Center for Integrative Medical Sciences</institution><addr-line><named-content content-type="city">Yokohama</named-content></addr-line><country>Japan</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Department of Microbiology and Immunology</institution><institution>Keio University School of Medicine</institution><addr-line><named-content content-type="city">Tokyo</named-content></addr-line><country>Japan</country></aff><aff id="aff7"><label>7</label><institution>Vedanta Biosciences</institution><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution content-type="dept">Engineering and Applied Sciences PhD Program</institution><institution>University of Massachusetts Dartmouth</institution><addr-line><named-content content-type="city">North Dartmouth</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution content-type="dept">Graduate School of Frontier Sciences</institution><institution>The University of Tokyo</institution><addr-line><named-content content-type="city">Kashiwa</named-content></addr-line><country>Japan</country></aff><aff id="aff10"><label>10</label><institution content-type="dept">Massachusetts Host-Microbiome Center, Department of Pathology</institution><institution>Brigham and Women’s Hospital, Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff11"><label>11</label><institution content-type="dept">Department of Cell Biology</institution><institution>Harvard Medical School</institution><addr-line><named-content content-type="city">Boston</named-content></addr-line><country>United States</country></aff><aff id="aff12"><label>12</label><institution content-type="dept">Department of Biology</institution><institution>University of Massachusetts Dartmouth</institution><addr-line><named-content content-type="city">North Dartmouth</named-content></addr-line><country>United States</country></aff><aff id="aff13"><label>13</label><institution content-type="dept">Center for Microbial Informatics and Statistics</institution><institution>University of Massachusetts Dartmouth</institution><addr-line><named-content content-type="city">North Dartmouth</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-31673"><name><surname>Knight</surname><given-names>Rob</given-names></name><role>Reviewing Editor</role><aff id="aff14"><institution>University of California, San Diego</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>17</day><month>04</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e30916</elocation-id><history><date date-type="received" iso-8601-date="2017-08-01"><day>01</day><month>08</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2018-03-31"><day>31</day><month>03</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Stein et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Stein et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-30916-v2.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.30916.001</object-id><p>Manipulation of the gut microbiota holds great promise for the treatment of diseases. However, a major challenge is the identification of therapeutically potent microbial consortia that colonize the host effectively while maximizing immunologic outcome. Here, we propose a novel workflow to select optimal immune-inducing consortia from microbiome compositicon and immune effectors measurements. Using published and newly generated microbial and regulatory T-cell (T<sub>reg</sub>) data from germ-free mice, we estimate the contributions of twelve Clostridia strains with known immune-modulating effect to T<sub>reg</sub> induction. Combining this with a longitudinal data-constrained ecological model, we predict the ability of every attainable and ecologically stable subconsortium in promoting T<sub>reg</sub> activation and rank them by the T<sub>reg</sub> Induction Score (TrIS). Experimental validation of selected consortia indicates a strong and statistically significant correlation between predicted TrIS and measured T<sub>reg</sub>. We argue that computational indexes, such as the TrIS, are valuable tools for the systematic selection of immune-modulating bacteriotherapeutics.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.30916.002</object-id><title>eLife digest</title><p>The role of the immune system is to protect the body from infection. It does this by using a powerful toolkit that isolates pathogens and removes damaged tissue. When directed against bacteria and viruses, the system helps to keep the body safe, but an imbalance of the components of the immune system can lead to inflammatory or allergic diseases.</p><p>The body has built-in mechanisms to shut off the immune response. For example, regulatory T-cells are immune cells with an anti-inflammatory effect, meaning they can switch off inflammation after the immune system has cleared an invasion. If their numbers are too low, it can contribute to unwanted inflammation. In ulcerative colitis, for instance, an unbalanced immune system mistakenly attacks healthy tissue. This causes inflammation and ulcers in the intestine, resulting in bleeding and weight loss.</p><p>Previous studies revealed that bacteria in the gut might help to control regulatory T-cell numbers. Certain combinations of bacteria can stimulate these regulatory T-cells and potentially dampen inflammation. Tweaking the different populations of microbes in the gut could provide a new way to treat diseases like ulcerative colitis. But, identifying the best combination to use is a major challenge. Testing them all one by one would be extremely challenging. Now, Stein, Tanoue et al. present a mathematical model designed to predict the best microbe-mix to use.</p><p>The model incorporated data from regulatory T-cells and microbes gathered from mice to estimate the contribution that different strains of bacteria make to regulatory T-cell numbers. This then fed into an ecological model predicted how different combinations of bacteria would behave in mice. The model aimed to fulfill two key criteria. First, to find combinations that can form stable, long-term bacterial colonies alone and when faced with competing microbes. Second, to boost regulatory T-cell numbers, helping them to expand to correct the immune imbalance.</p><p>To test the predictions, mice received combinations of bacteria suggested by the model. The model had predicted some combinations to be 'weak' at inducing regulatory T-cells, some 'intermediate' and some 'strong'. The results matched the predictions, validating the method.</p><p>This new model allows the rapid design of microbes that could dampen the immune response in the gut and paves the way for new treatments to correct imbalances of the immune system. By using already available data, it should be possible to expand the model to other diseases with imbalance in the immune system. In future, similar models could also find combinations for other medical uses. For example, to optimise the delivery of cancer immunotherapy, or to modulate the immune system after an organ transplant.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>host–microbe interaction</kwd><kwd>regulatory T-cells</kwd><kwd>immune system modulation</kwd><kwd>microbiome modeling</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P41 GM103504</award-id><principal-award-recipient><name><surname>Stein</surname><given-names>Richard R</given-names></name><name><surname>Sander</surname><given-names>Chris</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000185</institution-id><institution>Defense Advanced Research Projects Agency</institution></institution-wrap></funding-source><award-id>BRICS award HR0011-15-C-0094</award-id><principal-award-recipient><name><surname>Gerber</surname><given-names>Georg K</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000854</institution-id><institution>Human Frontier Science Program</institution></institution-wrap></funding-source><award-id>RGP00055/2015</award-id><principal-award-recipient><name><surname>Sander</surname><given-names>Chris</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007449</institution-id><institution>Takeda Science Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Honda</surname><given-names>Kenya</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>5R01 GM106303</award-id><principal-award-recipient><name><surname>Sander</surname><given-names>Chris</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Honda</surname><given-names>Kenya</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R15-AI112985-01A1</award-id><principal-award-recipient><name><surname>Bucci</surname><given-names>Vanni</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>1458347</award-id><principal-award-recipient><name><surname>Bucci</surname><given-names>Vanni</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003382</institution-id><institution>Core Research for Evolutional Science and Technology</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Honda</surname><given-names>Kenya</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005292</institution-id><institution>Brigham and Women's Hospital</institution></institution-wrap></funding-source><award-id>Precision Medicine Initiative</award-id><principal-award-recipient><name><surname>Gerber</surname><given-names>Georg K</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A computational method is presented that quantifies the effect that specific bacteria in the gut have on the immune system and guides the design of therapeutically potent microbial consortia to cure auto-immune disease.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The intestinal microbiota has been shown to critically influence a multitude of host physiological functions, often through modulation of the immune system (<xref ref-type="bibr" rid="bib17">Gevers et al., 2014</xref>; <xref ref-type="bibr" rid="bib28">Paun et al., 2016</xref>). Evidence includes studies in germ-free mice, which show that both pro-inflammatory T-helper 17 (T<sub>h</sub>17) cells and anti-inflammatory regulatory T-cells (T<sub>reg</sub>) are reduced in numbers in the intestinal lamina propria relative to conventional or specific pathogen-free mice (<xref ref-type="bibr" rid="bib2">Atarashi et al., 2008</xref>), and that repopulation with specific bacteria can reconstitute them (<xref ref-type="bibr" rid="bib4">Atarashi et al., 2015</xref>; <xref ref-type="bibr" rid="bib21">Ivanov et al., 2009</xref>). One route to how the microbiota influences immune system activation is by the production of small molecules (<xref ref-type="bibr" rid="bib11">Donia and Fischbach, 2015</xref>). Microbially produced short-chain fatty acids (SCFAs) were shown to facilitate extrathymic differentiation of immune system modulatory T<sub>reg</sub> (<xref ref-type="bibr" rid="bib1">Arpaia et al., 2013</xref>; <xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>; <xref ref-type="bibr" rid="bib32">Smith et al., 2013</xref>) and are implicated in T<sub>reg</sub>-dependent anti-inflammatory properties of a mix of 17 human-derived Clostridia strains (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>; <xref ref-type="bibr" rid="bib36">Tanoue et al., 2016</xref>). Interestingly, individual Clostridia strains only have a modest effect on T<sub>reg</sub> induction – optimal induction relies on the synergistic interplay of several strains (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>; <xref ref-type="bibr" rid="bib6">Belkaid and Hand, 2014</xref>). Because of these properties, there is currently great interest in the manipulation of this community for the treatment of inflammatory and allergic diseases (<xref ref-type="bibr" rid="bib20">Honda and Littman, 2012</xref>; <xref ref-type="bibr" rid="bib26">Olle, 2013</xref>; <xref ref-type="bibr" rid="bib38">Vieira et al., 2016</xref>). Efforts involving transplantation of bacteria from healthy humans to humans with <italic>C. difficile</italic> infections or with metabolic diseases have provided evidence that microbiota repopulation could be used as possible strategy for disease prevention and treatment (<xref ref-type="bibr" rid="bib37">van Nood et al., 2013</xref>; <xref ref-type="bibr" rid="bib39">Vrieze et al., 2012</xref>). For this reason, intestinal supplementation of defined compositions of gut bacteria to treat a range of diseases is currently being pursued by multiple bio-pharmaceutical companies (<xref ref-type="bibr" rid="bib13">Garber, 2015</xref>). Determining what microbial consortia can colonize the host and stably coexist with an already resident microbial community, while inducing the desired immune response, is still a major challenge that hinders the translation of these efforts into the clinic (<xref ref-type="bibr" rid="bib22">Maldonado-Gómez et al., 2016</xref>; <xref ref-type="bibr" rid="bib41">Weil and Hohmann, 2015</xref>).</p><p>In previous work, some of us identified a set of 17 potent T<sub>reg</sub>-inducing Clostridia strains to select candidate subsets from (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>). The determination of maximally immune-phenotype inducing combinations from these 17 strains is, however, experimentally infeasible as it would require the testing of 2<sup>17</sup>–1 = 131071 possible subsets in mice (<xref ref-type="bibr" rid="bib12">Faith et al., 2014</xref>). Therefore, a computational approach to prioritize which subsets to validate experimentally would have great utility. To our knowledge, to date there has been no model that allows for the simultaneous prediction of the dynamics of both the microbiota and the host immune response. Building on the approach to select for optimal bacterial combinations from (<xref ref-type="bibr" rid="bib12">Faith et al., 2014</xref>) and other efforts aimed at identifying potential immune-modulating microbes (<xref ref-type="bibr" rid="bib16">Geva-Zatorsky et al., 2017</xref>; <xref ref-type="bibr" rid="bib31">Schirmer et al., 2016</xref>), we overcome this problem by proposing a mathematical modeling-based framework that, by resolving microbiome–immune system interactions with parameters constrained to experimental observations of microbiome and immune effectors, allows computational optimization of immune-stimulating bacterial combinations. To achieve this, we use a series of logically connected analyses that capture CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> accumulation in the colonic lamina propria (<xref ref-type="bibr" rid="bib27">Omenetti and Pizarro, 2015</xref>; <xref ref-type="bibr" rid="bib29">Round and Mazmanian, 2010</xref>) in response to the dynamics of human-derived Clostridia strains in germ-free mice, which had previously been shown to potently induce T<sub>reg</sub> expansion (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>) (<xref ref-type="fig" rid="fig1">Figure 1</xref>). To constrain this proposed model framework to experimental data, we combine previously published (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>) and newly generated fluorescence-activated cell scanning (FACS) data with simulated and newly generated time-series colonization data from germ-free mice (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Subsequently, by applying a microbiome–T<sub>reg</sub> mathematical model to this combined data set, we infer each strain’s individual contribution to the CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> pool (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) and obtain an estimate of every possible consortium’s T<sub>reg</sub> induction potential. To justify the usage of predicted mono-colonization concentrations from a previously developed microbiome ecological model (<xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref>), we validate its ability in predicting temporal dynamics in response to different subsets of T<sub>reg</sub>-inducing strains (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) and quantify the deviation of data and predictions (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Introduction of the TrIS, which assigns a score to every predicted steady-state microbial composition, enables us to identify combinations that robustly maximize T<sub>reg</sub> induction (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). We analyze the relationship of TrIS and biomass (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) as well as metabolic features of the consortia (<xref ref-type="fig" rid="fig4">Figure 4C and D</xref>). Most importantly, we demonstrate the utility of our approach in predicting the potency of selected microbial combinations by validating the T<sub>reg</sub> induction and colonization ability of model-predicted strong, intermediate and weak T<sub>reg</sub>-inducing consortia <italic>in vivo</italic> (<xref ref-type="fig" rid="fig4">Figure 4E</xref>).</p><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.30916.003</object-id><label>Figure 1.</label><caption><title>Conceptual figure.</title><p>A microbiome–immune system mathematical model describing the activation of regulatory T-cells (T<sub>reg</sub>) in response to colonization profiles of T<sub>reg</sub>-stimulating Clostridia strains is the central element of this work. It consists of a previously derived microbiome ecological model that describes the short and long-term temporal dynamics of Clostridia strains in germ-free mice (<xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref>) and is supplemented by a microbiome–T<sub>reg</sub> model of CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> activation in response to long-term compositions in the microbiome. The individual contribution of each strain to the measured T<sub>reg</sub> activation is inferred using long-term colonization data from mouse experiments with subsets of these strains and corresponding measurements of T<sub>reg</sub> induction. The T<sub>reg</sub>-induction score, TrIS, which accounts for ecological stability and immune activation, assigns a score to every possible strain combination and thereby identifies candidate probiotic consortia for experimental validation.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-30916-fig1-v2"/></fig><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.30916.004</object-id><label>Figure 2.</label><caption><title>Data used for inference of the CD4<sup>+</sup>FOXP3<sup>+</sup>T<sub>reg</sub> induction parameters.</title><p>(<bold>A</bold>) To infer the strain-resolved CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> induction parameters CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> abundance measurements and corresponding microbiome colonization data are used. CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> data of single strains originates from previously published measurements from <xref ref-type="bibr" rid="bib5">Atarashi et al. (2013)</xref>. Because in <xref ref-type="bibr" rid="bib5">Atarashi et al. (2013)</xref> microbial mono-colonization levels were not measured, a previously published predictive model (<xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref>) was used to simulate these experiments. In addition, newly generated CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> and colonization mouse stool data from three 11-strain combinations was included into the analysis (see also <xref ref-type="fig" rid="fig3">Figure 3</xref>). The 11-strain combinations were chosen according to results of the ‘keystoneness’ analysis previously described in <xref ref-type="bibr" rid="bib8">Bucci et al. (2016)</xref>. The microbiome compositions of these three 11-strain combinations were estimated by strain-specific qPCR. (<bold>B</bold>) The resulting CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> induction parameters quantify the contribution of each individual strain to T<sub>reg</sub> induction. (Coefficients are scaled by the microbial mono-colonization concentrations for display reasons.)</p><p><supplementary-material id="fig2sdata1"><object-id pub-id-type="doi">10.7554/eLife.30916.005</object-id><label>Figure 2—source data 1.</label><caption><title>Data containing the microbiome compositions, the corresponding measured CD4<sup>+</sup>FOXP3<sup>+</sup> proportions and the derived induction parameters.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-30916-fig2-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-30916-fig2-v2"/></fig><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.30916.006</object-id><label>Figure 3.</label><caption><title>Validation of microbiome model describing the dynamics of Clostridia strains in germ-free mice.</title><p>(<bold>A</bold>) The model-predicted dynamics of three 11-strain combinations from the 13 Clostridia strains described in <xref ref-type="bibr" rid="bib8">Bucci et al. (2016)</xref> (areas) are compared to measured data from germ-free mice (stacked bars) and each panel corresponds to an individual mouse (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Predictions were obtained by numerically integrating the corresponding generalized Lotka–Volterra equations with parameters from <xref ref-type="bibr" rid="bib8">Bucci et al. (2016)</xref> using only each mouse’s initial microbial composition. In timelines/mouse 1–5, Strain 15 is absent referring to 11-strain set I (five biological replicates); in timelines 6–9, Strain 4 is absent (11-strain set II; four biological replicates), and in timelines 10–14, Strain 29 is absent (11-strain set III; five biological replicates). Data were obtained by qPCR of genes specific to each strain. Densities are computed as averages of three technical replicates. The number of mice used in each condition was chosen consistently with previous experimental work (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>; <xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref>) and combined with extensive <italic>in silico</italic> testing of the inference error as a function of sampling frequency and noise levels (<xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref>). (<bold>B</bold>) Spearman’s rank correlation coefficient between observed and predicted data was computed at different time points. All displayed coefficients have a p-value of less than 10<sup>−16</sup>.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-30916-fig3-v2"/></fig><fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.30916.007</object-id><label>Figure 4.</label><caption><title>Identification and experimental validation of model-predicted T<sub>reg</sub>-stimulating consortia.</title><p>(<bold>A</bold>) Predicted T<sub>reg</sub> Induction Score (TrIS) in germ-free mice as a function of probiotic consortium size. Each data point represents one of the 2<italic><sup>N</sup></italic>−1 possible non-trivial consortia of size <italic>N</italic>. The five highest and lowest TrIS consortia of size seven are highlighted by violet and cyan filled dots, respectively, as well as, the 4-strain consortia used for experimental validation in subpanel E. (<bold>B</bold>) Distribution of the TrIS plotted against the total population density of each model-predicted consortium. This analysis shows a strong correlation (Spearman’s Rank Correlation with coefficient 0.88 and p&lt;0.05) between TrIS and total microbial density. The color of each dot represents the abundance of Strain 27, which is predicted to strongly colonize in high-TrIS subsets. (<bold>C</bold>) Heatmap of consortium membership of the five highest and lowest TrIS-consortia of size seven and their predicted T<sub>reg</sub> induction and estimated butyrate production using data from <xref ref-type="bibr" rid="bib5">Atarashi et al. (2013)</xref>. (<bold>D</bold>) Estimation of potential SCFA output based on single-strain <italic>in vivo</italic> metabolic profiling from <xref ref-type="bibr" rid="bib5">Atarashi et al. (2013)</xref>. The five highest TrIS consortia of size seven (from 4C) are predicted to have a significantly higher SCFA output relative to the five lowest ones. (<bold>E</bold>) Five 4-strain consortia were used for experimental validation: the two highest-ranked consortia (H1 and H2, respectively), the lowest-ranked consortium (L) and two intermediates (M1, M2). M1 and M2 were included because of interest in other disease areas. The experimentally introduced strains are listed next to each bar/consortium. Strains with numbers in black were detected by 16S rRNA sequencing in mouse stool samples, strains with numbers in gray were introduced but failed to colonize. A Pearson’s correlation of 0.97 between the predicted TrIS and the average of each consortium’s measured CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> percentage proves the ability of the TrIS-based selection to correctly recover the experimentally observed T<sub>reg</sub> induction. (Pearson’s correlation of all points has a value of 0.54.) Importantly, the H2 consortium displays an average increase in immune activity of 107% relative to the average germ-free mouse control. Eight biological replicates were used for GF, H1 and H2, five biological replicates were used for M1, M2 and three biological replicates were used for L. Replication and design of the validation experiment for T<sub>reg</sub> induction assessment is consistent with work from us and others (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>; <xref ref-type="bibr" rid="bib25">Narushima et al., 2014</xref>).</p><p><supplementary-material id="fig4sdata1"><object-id pub-id-type="doi">10.7554/eLife.30916.010</object-id><label>Figure 4—source data 1.</label><caption><title>TrIS, TrIS rank and predicted median steady-state concentrations of the selected microbial consortia from <xref ref-type="fig" rid="fig4">Figure 4E</xref>.</title></caption><media mime-subtype="excel" mimetype="application" xlink:href="elife-30916-fig4-data1-v2.xls"/></supplementary-material></p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-30916-fig4-v2"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.30916.008</object-id><label>Figure 4—figure supplement 1.</label><caption><title>TrIS versus estimated mean population density.</title><p>In contrast to <xref ref-type="fig" rid="fig4">Figure 4B</xref>, which highlights only the abundance of Strain 27 in each consortium, the predicted total population density of the microbial consortia is compared to the TrIS while the color in each subpanel represents the corresponding strain’s abundance.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-30916-fig4-figsupp1-v2"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.30916.009</object-id><label>Figure 4—figure supplement 2.</label><caption><title>Metabolic profiling of three selected microbial consortia and comparison of predicted and measured metabolic profiles of three selected microbial consortia. </title><p>(<bold>A</bold>) Metabolic profiling results of fecal content of selected consortia with respect to acetic acid. (<bold>B</bold>) Comparison of predicted mean germ-free normalized acetate concentrations based on single-strain measurements in caecal content from (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>) with the observed germ-free mean normalized acetic acid levels in mouse stool from (A).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-30916-fig4-figsupp2-v2"/></fig></fig-group><p>We envision that our framework, while in this study tailored to finding combinations ameliorating auto-inflammatory conditions, may also have direct relevance to other immune-system enhancing applications such as the optimal delivery of probiotic-based cancer immunotherapies (<xref ref-type="bibr" rid="bib14">Garrett, 2015</xref>).</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Generation of multimodal microbiome–T<sub>reg</sub> data set</title><p>The goal of this study is to develop a mathematical modeling-based framework to rapidly and systematically select microbial consortia that maximize a desired immune outcome when introduced in a specific host microbial background. To achieve this, we combine (i) a microbiome ecological model that accurately describes the dynamics of these bacteria in the host with (ii) a microbiome–T<sub>reg</sub> mathematical model that characterizes the contribution of every strain to the immune phenotype of interest given corresponding microbiome colonization data (<xref ref-type="fig" rid="fig1">Figure 1</xref>). For (i), we gathered newly produced quantitative polymerase chain reaction (qPCR) colonization data from gnotobiotic mice and combined it with a previously published microbiome ecological model of the dynamics of 12 T<sub>reg</sub>-inducing Clostridia strains that are part of an original consortium of 17 T<sub>reg</sub>-inducing strains discovered by some of us (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>) (see also <xref ref-type="table" rid="table1">Table 1</xref> for a breakdown of strains used in each study). In contrast to the original study of (<xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref>), we included only 12 of the 13 strains used there because, based on the modeling and analysis of <xref ref-type="bibr" rid="bib8">Bucci et al. (2016)</xref>, Strain 6 from the 13-strain set was predicted to not stably colonize in the presence of the other 12 strains. The published colonization data have been reported in our previous work (<xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref>) and include time-series measurements of microbial abundances by qPCR under dietary perturbations. These are used to derive a predictive microbiome ecology model in gnotobiotic conditions based on an extension of the generalized Lotka–Volterra (gLV) equations (<xref ref-type="bibr" rid="bib19">Hofbauer and Sigmund, 1998</xref>) as introduced in <xref ref-type="bibr" rid="bib34">Stein et al. (2013)</xref>. For the newly generated dataset, we gavaged 14 mice with one of three possible 11-strain subsets from the 12-strain subset of original 13 strains (<xref ref-type="fig" rid="fig2">Figure 2</xref>) and used the derived stool measurements to validate the ability of our mathematical model in predicting unseen conditions. The three 11-strain subsets were chosen based on our ‘keystoneness’ definition, a measure describing the marginal predicted quantitative effect of removing each strain from the full community (<xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref>). Specifically, we included two 11-strain combinations each missing one of the two highest keystoneness-scoring strains (VE202 Strain 15 and VE202 Strain 4) and one 11-strain combination which lacks the lowest keystoneness scoring strain (VE202 Strain 29). In analogy to <xref ref-type="bibr" rid="bib8">Bucci et al. (2016)</xref>, each strain’s density was profiled over time by qPCR with strain-specific primers (see Materials and methods). To resolve the contribution of each of these to T<sub>reg</sub> induction for point (ii) we coupled the colonization data from fecal content with newly collected and published FACS measurements of the CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> population in the lamina propria of these mice (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). As it is crucial to capture each strain’s contribution alone and in combination with others, we also included CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> measurements from our previously published mono-colonization experiments (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Due to the fact that the single-strain mono-colonization concentrations were not measured in these experiments (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>), we simulated them using the microbiome ecological model and parameters from (<xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref>). This choice was supported by the model's capability in predicting unseen validation data (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Spearman’s rank-order correlation coefficient ranges from 0.92 to 0.98 (p-value&lt;10<sup>−16</sup>) between observations and predictions depending on the time point (<xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p><table-wrap id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.30916.011</object-id><label>Table 1.</label><caption><title>List of strains used with respect to our previous published work.</title><p>The original publication (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>) reported on 17 immune-modulating bacteria. In <xref ref-type="bibr" rid="bib8">Bucci et al. (2016)</xref>, a dynamical ecological model for 13 of the original 17 strains was presented. These 13 strains were selected because they do not harbor antibiotic resistance genes. For our study, we used a 12-strain subset of these 13 strains based on ecological stability considerations. Colonization and CD4<sup>+</sup>FOXP3<sup>+</sup>T<sub>reg</sub> data for the three 11-strain sets, measured by qPCR and FACS, were used along with the simulated mono-colonization concentrations (<xref ref-type="fig" rid="fig2">Figure 2</xref>) and included into the microbiome–immune system model (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The resulting parameters were employed to predict ecologically stable subsets with different T<sub>reg</sub> induction potentials. 4-strain subsets were selected to validate the predictions of the mathematical model (see main text and <xref ref-type="fig" rid="fig3">Figure 3</xref>). Strain 1: <italic>Clostridium saccharogumia</italic>/<italic>Clostridium ramosum</italic> JCM1298, Strain 3: <italic>Flavonibacter plautii</italic>/<italic>Pseudoflavonifractor capillosus</italic>, Strain 4: <italic>Clostridium hathewayi</italic>/<italic>Clostridium saccharolyticum</italic> WM1, Strain 6: <italic>Blautia coccoides</italic>/<italic>Lachnospiraceae bacterium</italic>, Strain 7: <italic>Clostridium bolteae</italic>, Strain 8: <italic>Clostridium sp.</italic> MLG055/<italic>Erysipelotrichaceae bacterium</italic> 2 44A, Strain 9: <italic>Clostridium indolis</italic>/<italic>Anaerostipes caccae</italic> DSM 14662, Strain 13: <italic>Anaerotruncus colihominis</italic>, Strain 14: <italic>Ruminococcus sp.</italic> ID8/<italic>Lachnospiraceae bacterium</italic> 2 1 46FAA, Strain 15: <italic>Clostridium asparagiforme</italic>/<italic>Clostridium lavalense</italic>, Strain 16: <italic>Clostridium symbiosum</italic>, Strain 18: <italic>Clostridium ramosum</italic>, Strain 21: <italic>Eubacterium fissicatena</italic>/<italic>Eubacterium contortum</italic>/<italic>Clostridium sp.</italic> D5, Strain 26: <italic>Clostridium scindens</italic>/<italic>Lachnospiraceae bacterium</italic> 5 1 57FAA, Strain 27: <italic>Lacnospiraceae bacterium</italic> A4/<italic>Lachno bacterium</italic> 3 1 57FAA CT1, Strain 28: <italic>Clostridium sp.</italic> 316002/08, Strain 29: <italic>Lacnospiraceae bacterium</italic> A4/<italic>Lachno bacterium</italic> 3 1 57FAA CT1.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th style="author-callout-style-b4"><xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref></th><th style="author-callout-style-b1"><xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref></th><th style="author-callout-style-b2">11-str. I</th><th style="author-callout-style-b2">11-str. II</th><th style="author-callout-style-b2">11-str. III</th><th style="author-callout-style-b7">H1</th><th style="author-callout-style-b7">H2</th><th style="author-callout-style-b7">M1</th><th style="author-callout-style-b7">M2</th><th style="author-callout-style-b7">L   </th></tr></thead><tbody><tr><td>Strain 1</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td style="author-callout-style-b1"/><td style="author-callout-style-b2"/><td style="author-callout-style-b2"/><td style="author-callout-style-b2"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/></tr><tr><td>Strain 3</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td style="author-callout-style-b1"/><td style="author-callout-style-b2"/><td style="author-callout-style-b2"/><td style="author-callout-style-b2"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/></tr><tr><td>Strain 4</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td align="center" style="author-callout-style-b1" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td style="author-callout-style-b2"/><td align="center" style="author-callout-style-b2" valign="middle">x</td><td style="author-callout-style-b7"/><td align="center" style="author-callout-style-b7" valign="middle">x</td><td align="center" style="author-callout-style-b7" valign="middle">x</td><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/></tr><tr><td>Strain 6</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td align="center" style="author-callout-style-b1" valign="middle">x</td><td style="author-callout-style-b2"/><td style="author-callout-style-b2"/><td style="author-callout-style-b2"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/></tr><tr><td>Strain 7</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td align="center" style="author-callout-style-b1" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b7" valign="middle">x</td><td align="center" style="author-callout-style-b7" valign="middle">x</td><td align="center" style="author-callout-style-b7" valign="middle">x</td><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/></tr><tr><td>Strain 8</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td style="author-callout-style-b1"/><td style="author-callout-style-b2"/><td style="author-callout-style-b2"/><td style="author-callout-style-b2"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/></tr><tr><td>Strain 9</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td align="center" style="author-callout-style-b1" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td align="center" style="author-callout-style-b7" valign="middle">x</td><td style="author-callout-style-b7"/></tr><tr><td>Strain 13</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td align="center" style="author-callout-style-b1" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/></tr><tr><td>Strain 14</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td align="center" style="author-callout-style-b1" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td align="center" style="author-callout-style-b7" valign="middle">x</td><td style="author-callout-style-b7"/><td align="center" style="author-callout-style-b7" valign="middle">x   </td></tr><tr><td>Strain 15</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td align="center" style="author-callout-style-b1" valign="middle">x</td><td style="author-callout-style-b2"/><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td align="center" style="author-callout-style-b7" valign="middle">x   </td></tr><tr><td>Strain 16</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td align="center" style="author-callout-style-b1" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td align="center" style="author-callout-style-b7" valign="middle">x</td><td align="center" style="author-callout-style-b7" valign="middle">x   </td></tr><tr><td>Strain 18</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td style="author-callout-style-b1"/><td style="author-callout-style-b2"/><td style="author-callout-style-b2"/><td style="author-callout-style-b2"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/></tr><tr><td>Strain 21</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td align="center" style="author-callout-style-b1" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/></tr><tr><td>Strain 26</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td align="center" style="author-callout-style-b1" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/></tr><tr><td>Strain 27</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td align="center" style="author-callout-style-b1" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b7" valign="middle">x</td><td align="center" style="author-callout-style-b7" valign="middle">x</td><td style="author-callout-style-b7"/><td align="center" style="author-callout-style-b7" valign="middle">x</td><td style="author-callout-style-b7"/></tr><tr><td>Strain 28</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td align="center" style="author-callout-style-b1" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b7" valign="middle">x</td><td style="author-callout-style-b7"/><td align="center" style="author-callout-style-b7" valign="middle">x</td><td style="author-callout-style-b7"/><td style="author-callout-style-b7"/></tr><tr><td>Strain 29</td><td align="center" style="author-callout-style-b4" valign="middle">x</td><td align="center" style="author-callout-style-b1" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td align="center" style="author-callout-style-b2" valign="middle">x</td><td style="author-callout-style-b2"/><td align="center" style="author-callout-style-b7" valign="middle">x</td><td align="center" style="author-callout-style-b7" valign="middle">x</td><td style="author-callout-style-b7"/><td align="center" style="author-callout-style-b7" valign="middle">x</td><td align="center" style="author-callout-style-b7" valign="middle">x   </td></tr></tbody></table></table-wrap></sec><sec id="s2-2"><title>Derivation of the microbiome–T<sub>reg</sub> mathematical model</title><p>We used the described microbiome colonization data and corresponding CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> measurements to determine the contribution of each strain to the T<sub>reg</sub> pool. We begin by subdividing the population of CD4<sup>+</sup> T-cells into two major subpopulations depending on their intracellular FOXP3 expression: CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> and the remainder among the CD4<sup>+</sup> T-cells, the conventional CD4<sup>+</sup>FOXP3<sup>−</sup> T-cells (<xref ref-type="bibr" rid="bib7">Bilate and Lafaille, 2012</xref>; <xref ref-type="bibr" rid="bib30">Rudensky, 2011</xref>). The concentration of CD4<sup>+</sup> T-cells at time <inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula> in the colonic lamina propria, <inline-formula><mml:math id="inf2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>T</mml:mtext></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula>, is then the combination of these two T-cell populations, <inline-formula><mml:math id="inf3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>T</mml:mtext></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>. To include a variety of effects into our model, we assume T-cell dynamics to follow the gLV equations (<xref ref-type="bibr" rid="bib15">Gerber, 2014</xref>; <xref ref-type="bibr" rid="bib19">Hofbauer and Sigmund, 1998</xref>), which also account for the effect of the microbial strains in the lumen on the CD4<sup>+</sup>FOXP3<sup>−</sup> T-cell subpopulation. In addition, we use an extension of the standard gLV equations to include the impact of the Clostridia strains in terms of external perturbations (<xref ref-type="bibr" rid="bib34">Stein et al., 2013</xref>). The resulting microbiome–T<sub>reg</sub> mathematical model is found as,<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mrow><mml:mphantom><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:munderover></mml:mphantom></mml:mrow></mml:mrow><mml:mo fence="true" stretchy="true" symmetric="true"/></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mo fence="true" stretchy="true" symmetric="true"/><mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>+</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mi>ε</mml:mi><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula>where <inline-formula><mml:math id="inf4"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:math></inline-formula> denotes the basal growth rate and <inline-formula><mml:math id="inf5"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:math></inline-formula> the self-interaction term of the CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> population. The interaction terms <inline-formula><mml:math id="inf6"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf7"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:math></inline-formula> represent the effect of the CD4<sup>+</sup>FOXP3<sup>−</sup> T-cell on the CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> population and of the CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub>﻿ on the CD4<sup>+</sup>FOXP3<sup>−</sup> T-cell population, respectively (<xref ref-type="bibr" rid="bib10">d’Onofrio, 2005</xref>). Consequently, positive interaction parameters correspond to activation, negative ones to inhibition. Moreover, <inline-formula><mml:math id="inf8"><mml:msub><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub> <mml:mi/></mml:math></inline-formula> denotes the effect of strain <inline-formula><mml:math id="inf9"><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> on the CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> population. For long-term observations, <inline-formula><mml:math id="inf10"><mml:mi>t</mml:mi><mml:mo>→</mml:mo><mml:mi>∞</mml:mi></mml:math></inline-formula>, the dynamics of <inline-formula><mml:math id="inf11"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtext> </mml:mtext><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> are given by its (non-trivial) steady-state solution, which simplifies the then static microbiome–T<sub>reg</sub> mathematical model of the relative CD4<sup>+</sup>FOXP3<sup>+</sup> proportion in steady state, <inline-formula><mml:math id="inf12"><mml:msub><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext> <mml:mi mathvariant="normal"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:math></inline-formula>, to a linear regression problem,<disp-formula id="equ2"><label>(2)</label><mml:math id="m2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mover><mml:mi>α</mml:mi><mml:mo stretchy="false">~</mml:mo></mml:mover></mml:mrow><mml:mo>+</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mover><mml:mi>ε</mml:mi><mml:mo stretchy="false">~</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>Here, we use that the absolute and relative abundance of the CD4<sup>+</sup>FOXP3<sup>+</sup>T<sub>reg</sub> population are coupled by <inline-formula><mml:math id="inf13"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtext> </mml:mtext><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>T</mml:mtext><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">O</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">X</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> (see Materials and methods). We assume that the steady-state CD4<sup>+</sup> T-cell concentration is constant, <inline-formula><mml:math id="inf14"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>T,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mtext>const.</mml:mtext></mml:mrow></mml:mstyle></mml:math></inline-formula>, across all microbial compositions. We justify this because we are dealing with genetically similar mice and a set of closely related Clostridia. This assumption is however not justifiable when comparing non-colonized and colonized germ-free mice (<xref ref-type="bibr" rid="bib12">Faith et al., 2014</xref>).</p><p>Assigning to <inline-formula><mml:math id="inf15"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> the measured FACS-derived CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> proportions after 35 days and to <inline-formula><mml:math id="inf16"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> the corresponding microbial profiles, we infer each strain's contribution to the CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> pool (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) by solving <xref ref-type="disp-formula" rid="equ2">Equation (2)</xref> with an <inline-formula><mml:math id="inf17"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msup><mml:mi>ℓ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mstyle></mml:math></inline-formula>-penalized least-square regression with one shrinkage parameter, which is determined in a leave-one-sample-out cross-validation (<xref ref-type="bibr" rid="bib34">Stein et al., 2013</xref>). The resulting normalized root-mean square deviation on left-out samples was found to be 12%.</p></sec><sec id="s2-3"><title>Derivation of the T<sub>reg</sub> Induction Score (TrIS) and selection of T<sub>reg</sub>-inducing consortia</title><p>After deriving a model to predict our candidate strains dynamics in germ-free conditions and having resolved each strain’s contribution to T<sub>reg</sub> expansion, we aim to use this information to computationally select for consortia that maximize T<sub>reg</sub> induction while being ecologically robust (<xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref>; <xref ref-type="bibr" rid="bib34">Stein et al., 2013</xref>). To specify a measure of ecological robustness as well as immune induction potential for microbial consortia in germ-free mice, we define the T<sub>reg</sub> Induction Score (TrIS) as the average predicted regulatory T-cell activation of a given consortium of <italic>K</italic> strains <inline-formula><mml:math id="inf18"><mml:mfenced close="}" open="{" separators="|"><mml:mrow><mml:msub><mml:mrow><mml:mtext>strain</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>⋯</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mrow><mml:mtext>strain</mml:mtext></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mfenced></mml:math></inline-formula> while ignoring contributions from the host,<disp-formula id="equ3"><label>(3)</label><mml:math id="m3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtext>TrIS</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>⋯</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mo>}</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mtext>=</mml:mtext><mml:mfrac><mml:mn>1</mml:mn><mml:mi>N</mml:mi></mml:mfrac><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:munderover><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mover><mml:mi>ε</mml:mi><mml:mo stretchy="false">~</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:msubsup><mml:mi>c</mml:mi><mml:mrow><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>n</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mo>.</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>If the predicted steady state of the microbial consortium <inline-formula><mml:math id="inf19"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msubsup><mml:mi>c</mml:mi><mml:mrow><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>n</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mi>c</mml:mi><mml:mrow><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>n</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> that is computed from the <inline-formula><mml:math id="inf20"><mml:mi>n</mml:mi></mml:math></inline-formula>-th Markov Chain Monte Carlo (MCMC) parameter estimate (<xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref>) is biologically meaningful, i.e. positive, and stable, then <inline-formula><mml:math id="inf21"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msubsup><mml:mi>c</mml:mi><mml:mrow><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>n</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup></mml:mrow></mml:mstyle></mml:math></inline-formula> denotes the steady-state concentration of strain <inline-formula><mml:math id="inf22"><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>; otherwise <inline-formula><mml:math id="inf23"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msubsup><mml:mi>c</mml:mi><mml:mrow><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>n</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:msubsup></mml:mrow></mml:mstyle></mml:math></inline-formula> is set to 0. Hence, the value of the TrIS is indicative of the expected CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> induction (after removing the host contribution) and it is of the same unit as the FACS measurements. We evaluated TrIS for every possible strain combination that would stably colonize the gut in germ-free background. In our computation, of the 2<sup>12</sup>–1 = 4095 possible steady-state strain configurations evaluated in <italic>N</italic> = 22,500 MCMC parameter estimates, 84% are found to be biologically meaningful and stable. Interestingly, while the average TrIS increases with consortium size, our analysis shows that a subset size of seven already contains bacterial combinations maximizing induction (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Furthermore, in addition to the strong correlation between TrIS and the predicted total bacterial abundance in the consortium, we observed that high-induction consortia display an especially large enrichment in the abundance of Strain 27 (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Because short-chain fatty acids have been previously associated with colonic T<sub>reg</sub> induction (<xref ref-type="bibr" rid="bib1">Arpaia et al., 2013</xref>) and increase in density upon supplementation with these strains (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>), we decided to test if modeling-predicted high T<sub>reg</sub>-inducing consortia were also enriched in SCFAs. We therefore compared the top 5-inducing microbial consortia of size seven against their same-size counterpart bottom 5 (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). We predicted the SCFA concentration for each of the predicted compositions by summing the scaled metabolic outputs of each strain measured in mono-colonization experiments (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>; <xref ref-type="bibr" rid="bib25">Narushima et al., 2014</xref>) and normalized by the strain’s model-predicted mono-colonization density. We performed a Welch two-samples t-test for each of the predicted SCFAs concentrations and found significant enrichment for all estimated SCFAs (p&lt;0.05, one tailed) in the high-TrIS consortia compared to the low ones (<xref ref-type="fig" rid="fig4">Figure 4D</xref>).</p></sec><sec id="s2-4"><title>Experimental validation of mathematical model predictions</title><p>We decided to experimentally test our approach's ability to correctly predict consortium ranking with respect to T<sub>reg</sub>-induction. Due to regulatory constraints on the used probiotic strains – limiting us to a maximum of four strains at a time in follow-up experiments – we selected five 4-strain combinations with a variety of predicted immune effects. We measured CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> induction for five microbial consortia of size four and the germ-free control. We chose the two highest TrIS consortia (H1, H2 with rank 1 and 2, respectively), the lowest one (L with rank 495) and two TrIS-intermediate consortia of interest (M1, M2 with rank 129 and 452, respectively). Strains contained in each of the five consortia are detailed in <xref ref-type="table" rid="table1">Table 1</xref>. We correlated the TrIS score with the mean observed CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> percentage and found a significant Pearson correlation with coefficient of 0.97 and p-value&lt;0.01 (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Importantly, when using 16S rRNA sequencing to investigate the resulting colonization profiles for these combinations, we observed that the high TrIS-scoring consortia (H1, H2, M1) all stably colonized while the two low-scoring consortia only displayed a subset of the introduced strains. This result remarkably reflects the nature of our scoring system which, in addition to immune activation potential, also incorporates colonization success (<xref ref-type="disp-formula" rid="equ3">Equation 3</xref>).</p><p>Because the SCFA enrichment analysis from <italic>in vivo</italic> measurements of individual strains (<xref ref-type="fig" rid="fig4">Figure 4C</xref>) predicted acetate to be significantly increased in the five high versus low T<sub>reg</sub>-inducing consortia of size seven, we decided to compare the measured acetic acid concentrations (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>) to predictions of acetate in the two high (H1 and H2) and low (L) T<sub>reg</sub>-inducing 4-strain consortia (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>). ANOVA and subsequent post-hoc Tukey test showed significance in the measured enrichment of H1 compared to L (adjusted p-value&lt;0.05) and of H1 compared to H2 (adjusted p-value&lt;0.05) (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). However, no statistical difference was observed between measurements in H2 and L (adjusted p-value&lt;0.05). Remarkably, the model-predicted germ-free normalized acetate enrichment and the observed acetic acid concentration (normalized by the mean in germ-free conditions) are well correlated (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Manipulation of the intestinal microbiota with defined bacterial consortia for the treatment of disease is a promising route for future therapeutics (<xref ref-type="bibr" rid="bib18">Hansen and Sartor, 2015</xref>). However, choosing bacterial combinations from the vast combinatorial space of microbes that effectively colonize a host (possibly with a dysbiotic microbiota) and at the same time maximize a desired host phenotype requires an enormous number of expensive and time-consuming experimental trials (<xref ref-type="bibr" rid="bib12">Faith et al., 2014</xref>). While data mining and statistical approaches could aid in this process, the majority of available microbiome analysis methods is still based on correlations (<xref ref-type="bibr" rid="bib15">Gerber, 2014</xref>; <xref ref-type="bibr" rid="bib24">Morgan et al., 2015</xref>) and inept at predicting unseen phenotypes. Identification of causal associations between microbes and host phenotype has been recently achieved by using an experimentally based microbe–phenotype triangulation (<xref ref-type="bibr" rid="bib35">Surana and Kasper, 2017</xref>). However, this approach remains impractical when the goal is to explore and rank all possible microbiome consortium combinations with respect to a host phenotype of interest. In this study, we leveraged our previous computational methods to forecast temporal microbiome dynamics and make predictions on stability in the context of infectious and inflammatory diseases including <italic>C. difficile</italic> colonization and inflammatory bowel disease (<xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref>; <xref ref-type="bibr" rid="bib9">Buffie et al., 2015</xref>; <xref ref-type="bibr" rid="bib34">Stein et al., 2013</xref>). </p><p>Specifically, we have presented a novel modeling-based method that combines dynamical predictions from data-driven models of the microbiome and the interactions between microbes and the immune response (such as CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub>) and thereby enables the rational design of immune-modulating bacterial consortia. Limiting our scope to long-term steady-state dynamics, we were able to derive a microbiome–T<sub>reg</sub> mathematical model which is constrained by experimental observations from multimodal data. In the presented work, the used data modalities are qPCR and 16S rRNA sequencing data to estimate microbial abundances and FACS to assess CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> induction, respectively. However, the proposed framework is naturally extensible to other host data, for example data from metabolite profiling, immune readouts (e.g. CD8 T-cell activation, T<sub>h</sub>1/T<sub>h</sub>17 cell depletion) or host transcriptome profiling (<xref ref-type="bibr" rid="bib3">Atarashi et al., 2017</xref>; <xref ref-type="bibr" rid="bib24">Morgan et al., 2015</xref>). To evaluate candidate consortia that could be relevant to the treatment of auto-inflammatory diseases, we introduced the T<sub>reg</sub> Induction Score, TrIS, as a novel metric that accounts for both ecological stability and efficacy in immune modulation. This metric allowed us to rationally identify combinations that would stably colonize and at the same time produce substantial T<sub>reg</sub> induction in germ-free mice. Remarkably, in validation experiments of five distinct modeling-guided consortia with predicted diverse induction potential, we proved the ability of our approach to successfully select microbial combinations with a desired therapeutic activity. To our knowledge, this is to date, the first study in which observation-constrained <italic>in silico</italic> modeling of microbiome and host phenotype has successfully guided the rational design of drugs of defined bacterial consortia.</p><p>Our work relies on the gLV model assumption for both microbiome and CD4<sup>+</sup> regulatory T-cell dynamics which, despite being very versatile, has some limitations including the lack of third or higher order interactions or saturation effects (<xref ref-type="bibr" rid="bib40">Wangersky, 1978</xref>). Moreover, with the data available to us, we needed to assume that the overall T-cell density at steady state is constant across mice and different microbiome compositions. While this assumption was reasonable for the data we analyzed (see Results), the addition of future measurements on total T-cell abundance will likely improve the prediction accuracy of our model as well as provide important insight into the variability of T-cell population size in response to microbial immune induction.</p><p>We performed our data and modeling analysis in germ-free mice. While previous work by some of us showed that the amount of T<sub>reg</sub> induction is independent of the germ-free background (IQI, Balb/c or C57BL/6) (<xref ref-type="bibr" rid="bib4">Atarashi et al., 2015</xref>), it is noteworthy that our model, which was trained on IQI mice data, robustly predicted both T<sub>reg</sub> induction and acetate enrichment of C57BL/6 colonized mice as used in the validation experiments.</p><p>Our predictions suggest some degree of consistency in terms of functional outcome (e.g. enrichment in acetate) of high-scoring consortia relative to low-scoring ones in germ-free mice. However, before translating these findings into therapeutic development, future studies will need to be performed in not germ-free settings (e.g. SPF mice, humanized mice) in order to account for the effects of an already-established flora. Individual-specific microbiome features may constrain the colonization potential of the selected strains due to specific ecological network effects (<xref ref-type="bibr" rid="bib33">Smits et al., 2016</xref>), which suggests the need for a careful characterization of the ecological interactions between the proposed probiotic product and a specific recipient community (e.g. a single ulcerative colitis patient (<xref ref-type="bibr" rid="bib5">Atarashi et al., 2013</xref>)).</p><p>Treatment of auto-immune diseases overall is not necessarily achieved by the exclusive optimization of one objective function (e.g. for ulcerative colitis, the maximization of T<sub>reg</sub> activation), but may need the simultaneous manipulation of a multi-process host immune spectrum, which could include the concomitant reduction of pro-inflammatory phenotypes (<xref ref-type="bibr" rid="bib4">Atarashi et al., 2015</xref>). Given new data availability and careful experimental design, we believe that the modeling framework proposed in this study could overcome these problems by introducing constraints into the scoring metric that account for pre-colonized mouse model features. To the limit, in the presence of a large training data set that would include sufficient information on individual patient variation, our workflow will give us the unprecedented potential of testing microbiota manipulation on a personalized level <italic>in silico</italic>.</p><p>Mathematical modeling-based methods have the potential to greatly accelerate the development of treatment of human disease (<xref ref-type="bibr" rid="bib23">Michor and Beal, 2015</xref>). In this work, we develop and demonstrate in a first-of-a-kind experimental validation the usefulness of a mathematical microbiome–immune system model. It can be considered a stepping-stone to the accelerated prototyping and rational design of microbiome therapies.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Derivation of the microbiome–T<sub>reg</sub> induction mathematical model</title><p>We assume the following dynamics for the CD4<sup>+</sup>FOXP3<sup>+</sup> regulatory T-cell population:<disp-formula id="equ4"><mml:math id="m4"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mtext>d</mml:mtext><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mtext>d</mml:mtext><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mspace linebreak="newline"/><mml:mo>+</mml:mo><mml:mtext> </mml:mtext><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mi>ε</mml:mi><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>Here, <inline-formula><mml:math id="inf24"><mml:msub><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:math></inline-formula> denotes the basal growth rate and <inline-formula><mml:math id="inf25"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:math></inline-formula> the self-interaction term of the CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> population, while the interaction parameters <inline-formula><mml:math id="inf26"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="inf27"><mml:msub><mml:mrow><mml:mi>β</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo></mml:mrow></mml:msup><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:math></inline-formula> characterize the effect of the CD4<sup>+</sup>FOXP3<sup>− </sup>T-cells on the CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> population and of the CD4<sup>+</sup>FOXP3<sup>+ </sup>T<sub>reg</sub> on the CD4<sup>+</sup>FOXP3<sup>−</sup> T-cell population, respectively (<xref ref-type="bibr" rid="bib10">d’Onofrio, 2005</xref>). Moreover, <inline-formula><mml:math id="inf28"><mml:msub><mml:mrow><mml:mi>ε</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub> <mml:mi/></mml:math></inline-formula> denotes the effect of strain <inline-formula><mml:math id="inf29"><mml:msub><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> on the CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> population. The non-trivial steady-state solution (i.e., the algebraic solution of the right-hand side of <xref ref-type="disp-formula" rid="equ1">Equation (1)</xref> set to 0 with <inline-formula><mml:math id="inf30"><mml:msub><mml:mrow><mml:mi>c</mml:mi></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mo>≠</mml:mo><mml:mn>0</mml:mn></mml:math></inline-formula>) is found as,<disp-formula id="equ5"><mml:math id="m5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="left left" columnspacing="1em" rowspacing="4pt"><mml:mtr><mml:mtd><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub><mml:mspace width="negativethinmathspace"/><mml:mspace width="negativethinmathspace"/><mml:mspace width="negativethinmathspace"/></mml:mtd><mml:mtd><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup><mml:mtext>, ss</mml:mtext></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mi>ε</mml:mi><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula></p><p>Using <inline-formula><mml:math id="inf31"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>T,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula> the steady-state concentrations of the CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> and CD4+FOXP3<sup>−</sup> populations, <inline-formula><mml:math id="inf32"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>, are derived from the FACS-based relative abundances <inline-formula><mml:math id="inf33"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> by, <inline-formula><mml:math id="inf34"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtext> </mml:mtext><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub><mml:mo>⋅</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">O</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">X</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext><mml:mrow><mml:mtext> </mml:mtext></mml:mrow><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>T,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">F</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">O</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">X</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>−</mml:mo><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>. Finally, the linear relationship between the relative abundances, <inline-formula><mml:math id="inf35"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>, and the strain densities, <inline-formula><mml:math id="inf36"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula>, is found as,<disp-formula id="equ6"><mml:math id="m6"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mtable columnalign="right left right left right left right left right left right left" columnspacing="0em 2em 0em 2em 0em 2em 0em 2em 0em 2em 0em" displaystyle="true" rowspacing="3pt"><mml:mtr><mml:mtd><mml:msub><mml:mi>r</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mtd><mml:mtd><mml:mi/><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mfrac><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>T,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mfrac><mml:mo>+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>+</mml:mo></mml:mrow></mml:msup><mml:mtext>FOXP</mml:mtext><mml:msup><mml:mn>3</mml:mn><mml:mrow><mml:mo>−</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>T,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mfrac><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mi>ε</mml:mi><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd><mml:mi/><mml:mo>≡</mml:mo><mml:mrow><mml:mover><mml:mi>α</mml:mi><mml:mo stretchy="false">~</mml:mo></mml:mover></mml:mrow><mml:mo>+</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>K</mml:mi></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mover><mml:mi>ε</mml:mi><mml:mo stretchy="false">~</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:msub><mml:mtext>strain</mml:mtext><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub><mml:mtext>,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mstyle></mml:math></disp-formula>assuming constant concentration of CD4<sup>+</sup> T-cells, <inline-formula><mml:math id="inf37"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mrow><mml:mtext>T,</mml:mtext><mml:mspace width="thinmathspace"/><mml:mtext>ss</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mtext>const</mml:mtext><mml:mo>.</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula>, across all possible microbiome compositions. The unknown parameters <inline-formula><mml:math id="inf38"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mrow><mml:mover><mml:mi>α</mml:mi><mml:mo stretchy="false">~</mml:mo></mml:mover></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula> and <inline-formula><mml:math id="inf39"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mrow><mml:mover><mml:mi>ε</mml:mi><mml:mo stretchy="false">~</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:msub><mml:mi>i</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:msub></mml:mrow></mml:mstyle></mml:math></inline-formula> are estimated in an <inline-formula><mml:math id="inf40"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msup><mml:mi>ℓ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mstyle></mml:math></inline-formula>-penalized least-square regression (so-called ridge regression) with a positive shrinkage parameter <inline-formula><mml:math id="inf41"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>λ</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula>, which is determined in a leave-one-sample-out cross-validation as <inline-formula><mml:math id="inf42"><mml:msup><mml:mrow><mml:mi>λ</mml:mi></mml:mrow><mml:mrow><mml:mi>*</mml:mi></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:math></inline-formula>.</p></sec><sec id="s4-2"><title>Collection of experimental data for training the microbiome–immune system model</title><sec id="s4-2-1"><title>Strain abundance profiling</title><p>In our previous work (<xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref>), we have inferred a mathematical model describing the dynamics of a 13-strain subset from the original 17-strain human-derived Clostridia consortium from <xref ref-type="bibr" rid="bib5">Atarashi et al. (2013)</xref> in germ-free mice. Using newly generated data from the same experimental setup, we are now able to assess its predictive quality for three distinct 11-strain subsets. The three 11-strain compositions were selected based on their capability to maintain stability in the simulations when either one of two high (Strain 15 and Strain 4, here referred to as cases I and II, respectively) or one low (Strain 29; III) keystone strain was removed (<xref ref-type="bibr" rid="bib8">Bucci et al., 2016</xref>). For the experimental validation, germ-free IQI mice were purchased from Sankyo Laboratories (Japan), randomized and maintained in germ-free vinyl isolators in the animal facility of RIKEN. Twelve T<sub>reg</sub>-inducing Clostridia strains were selected from the previously reported VE202 consortium consisting of 17 T<sub>reg</sub>-inducing strains (4, 7, 9, 13–16, 21, 26–29) and were individually cultured in modified Eggerth Gagnon broth under strictly anaerobic conditions (80% N<sub>2</sub>, 10% H<sub>2</sub>, 10% CO<sub>2</sub>) at 37°C in an anaerobic chamber (Coy Laboratory Products, Grass Lake, MI) to confluence. The cultured bacterial strains were then mixed and the three mixtures of 11 strains (described above) were orally inoculated into five IQI germ-free adult mice each. One mouse for condition II died and was therefore discarded from the study. After an initial 9-day interval of acclimation, we collected fecal pellets at 2–4 days interval until day 35, time at which mice were euthanized and analyzed for CD4<sup>+</sup>FOXP3 induction as in <xref ref-type="bibr" rid="bib5">Atarashi et al. (2013</xref>). Colonization levels for each strain were assessed by amplifying strain-specific regions with qPCR as described in <xref ref-type="bibr" rid="bib8">Bucci et al. (2016)</xref>. Bacterial genomic DNA was extracted from 1 to 2 fecal pellets using QIAamp DNA Stool Mini Kit (Qiagen, Hilden, Germany). The amount of DNA was quantified using a Qubit dsDNA HS assay kit and Qubit fluorometer (Invitrogen, Carlsbad, CA). DNA was then subjected to qPCR using Thunderbird SYBR qPCR Mix (TOYOBO, Osaka, Japan) and a LightCycler 480 (Roche) with primers specific to 16S ribosomal RNA (rRNA) genes of the 12 Clostridia strains as in <xref ref-type="bibr" rid="bib8">Bucci et al. (2016)</xref>. Quantification of each strain in each sample was accomplished using standard curves of known concentrations of DNAs purified from each strain individually cultured <italic>in vitro</italic>. Strain densities in each sample were calculated by dividing the above absolute quantification numbers by the weight of the extracted fecal DNA. The 11-strain experiments were ethically approved by RIKEN, Keio and Azabu Universities under protocol H24-9(14) from RIKEN.</p></sec></sec><sec id="s4-3"><title>Estimation of CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> – Isolation of intestinal lamina propria lymphocytes and flow cytometry</title><p>The colons were collected and opened longitudinally, washed with PBS to remove all luminal contents and shaken in Hanks’ balanced salt solution (HBSS) containing 5 mM EDTA for 20 min at 37°C. After removing epithelial cells, muscle layers and fat tissue using forceps, the lamina propria layers were cut into small pieces and incubated with RPMI1640 containing 4% fetal bovine serum, 0.5 mg/ml collagenase D, 0.5 mg/ml dispase and 40 mg/ml DNase I (all Roche Diagnostics, Risch-Rotkreuz, Switzerland) for 1 hr at 37°C in a shaking water bath. The digested tissues were washed with HBSS containing 5 mM EDTA, resuspended in 5 ml of 40% Percoll (GE Healthcare, Boston, MA) and overlaid on 2.5 ml of 80% Percoll in a 15 ml Falcon tube. Percoll gradient separation was performed by centrifugation at 850 <italic>g</italic> for 25 min at 25°C. The lamina propria lymphocytes were collected from the interface of the Percoll gradient and suspended in ice-cold PBS. For analysis of T<sub>reg</sub>, isolated lymphocytes were labeled with the LIVE/DEAD fixable dead cell stain kit (Life Technologies, Carlsbad, CA) to exclude dead cells from the analysis. Then, surface and intracellular staining of CD3, CD4 and FOXP3 was performed using the BV605-labeled anti-CD3 (17A2, Biolegend, San Diego, CA), BV421-labeled anti-CD4 (RM4-5, Biolegend), Alexa700-labeled anti-FOXP3 antibody (FJK-16 s, eBioscience, San Diego, CA), and FOXP3 staining buffer set (eBioscience). The antibody-stained cells were analyzed with LSR Fortessa and data were analyzed using FlowJo software (Tree Star, Ashland, OR).</p></sec><sec id="s4-4"><title>Measurement of organic acids</title><p>Organic acid concentrations in caecal contents were determined by gas chromatography-mass spectrometry (GC-MS). Caecal contents (10 mg) were disrupted using 3 mm zirconia/silica beads (BioSpec Products) and homogenized in extraction solution containing 100 ml of internal standard (100 mM crotonic acid), 50 ml of HCl and 200 ml of ether. After vigorous shaking using a Shakemaster neo (Bio Medical Science) at 1500 rpm for 10 min, homogenates were centrifuged at 1000 <italic>g</italic> for 10 min and then the top ether layer was collected and transferred into new glass vials. Aliquots (80 ml) of the ether extracts were mixed with 16 ml of N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA). The vials were sealed tightly by screwing and heated at 80°C for 20 min in a water bath, and left at room temperature for 48 hr for derivatization. The samples were then run through a 6890N Network GC System (Agilent Technologies) equipped with HP-5MS column (0.25 mm 330 m 30.25 mm) and 5973 Network Mass Selective Detector (Agilent Technologies, Santa Clara, CA). Pure helium (99.9999%) was used as a carrier gas and delivered at a flow rate of 1.2 ml/min. The head pressure was set at 10 psi with split 10:1. The inlet and transfer line temperatures were 250 µC and 260 µC, respectively. The following temperature program was used: 60 µC (3 min), 60–120°C (5°C/min), 120–300°C (20°C/min). One microliter quantity of each sample was injected with a run time of 30 min. Organic acid concentrations were quantified by comparing their peak areas with the standards.</p></sec><sec id="s4-5"><title>Numerical simulations of the three 11-strain subsets used for microbiome–T<sub>reg</sub> model training</title><p>We used 22,500 sets of Markov Chain Monte Carlo generalized Lotka–Volterra parameter sets determined by applying the Bayesian Variable Selection algorithm within MDSINE to the data of <xref ref-type="bibr" rid="bib8">Bucci et al. (2016)</xref>, and the first time point of measured microbial profiles for each of the 14 validation mice as initial condition, to simulate the gLV system of differential equations corresponding to each mouse microbiome (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Prediction accuracy was evaluated by calculating the Spearman correlation coefficient between observed and predicted data (<xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p></sec><sec id="s4-6"><title>Simulation of mono-colonization abundances</title><p>As the experimental data from <xref ref-type="bibr" rid="bib5">Atarashi et al. (2013)</xref> only provided CD4<sup>+</sup>FOXP3<sup>+</sup> T-cell levels for the mono-strain colonization experiments at 35 days after inoculation but no measurement of the long-term microbial concentrations in the gut, we used instead the corresponding estimated mono-strain colonization densities obtained from the gLV model (section above and <xref ref-type="fig" rid="fig2">Figure 2A</xref>). In general, the long-term behavior of the gLV system is determined by its steady states which are uniquely defined by the inferred model parameters (<xref ref-type="bibr" rid="bib34">Stein et al., 2013</xref>). We computed the parameter median in each single model variable from the 22,500 MCMC parameter sets. These median parameters were then used to deduce the steady-state densities, which were together with the measured CD4<sup>+</sup>FOXP3 proportions included into the training of the microbiome–T<sub>reg</sub> model.</p></sec><sec id="s4-7"><title>Collection of CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> data from 4-strain experiments for validation of the modeling-based predictions</title><p>Bacterial strains 4, 7, 9, 14, 15, 16, 27, 28, 29 were grown anaerobically in PYG broth (Peptone, Yeast and Glucose broth from Anaerobe Systems, Cat no: AS-822) until they reached stationary phase (48 hr for strains 27 and 29, 24 hr for the remaining strains). Each 200 µl-mouse dose of a 4-strain LBP contained 50 µl of 20 times concentrated stationary phase culture. Germ-free C57BL/6 mice aged 6–8 weeks were randomized and gavaged with a total dose of 5·10<sup>7</sup>–2·10<sup>8</sup> bacteria in a 200 µl, and maintained under gnotobiotic conditions for four weeks. Use of a C57BL/6 background for these experiments was motivated by availability of animals at the facility where we performed the validation and justified by the fact that previous work from us has shown that T<sub>reg</sub> induction by our Clostridia strains does not differ between Balb/c, IQI, and C57BL/6 mice (<xref ref-type="bibr" rid="bib4">Atarashi et al., 2015</xref>). Mice were then sacrificed, colons harvested, and lamina propria leukocytes isolated and stained for CD3<sup>+</sup>CD4<sup>+</sup>FOXP3<sup>+</sup> T<sub>reg</sub> as described above. Eight mice each were used for consortia High 1 (H1-strains: 7, 27, 28, 29) and High 2 (H2-strains: 4, 7, 27, 29). Five mice each were used for the intermediate high (M1-strains: 4, 7, 14, 28), and intermediate low consortia (M2-strains: 9, 16, 27, 29). Three mice were used for Low 1 (L1-strains: 14, 15, 16, 29). Colonization profiling was determined through 16S rRNA sequencing (as above) and verified by blasting representative sequences to a 16S VE202 fasta database. The 4-strain validation experiments were performed in the Massachusetts Host Microbiome Center under IACUC protocol 2016N000141.</p></sec></sec></body><back><sec id="s6" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Has received support from Vedanta Biosciences, Inc. under research agreement with his institution</p></fn><fn fn-type="COI-statement" id="conf3"><p>Is employee of Vedanta Biosciences, Inc</p></fn><fn fn-type="COI-statement" id="conf4"><p>Is the Chief Executive Officer of Vedanta Biosciences, Inc</p></fn><fn fn-type="COI-statement" id="conf5"><p>Jason M Norman: Is employee of Vedanta Biosciences, Inc</p></fn><fn fn-type="COI-statement" id="conf6"><p>Is a member of the Scientific Advisory Board of Kaleido, Inc</p></fn><fn fn-type="COI-statement" id="conf7"><p>Is a Co-Founder and Scientific Advisory Board Member of Vedanta Biosciences, Inc. Has received support from Vedanta Biosciences, Inc. under research agreements with his institution</p></fn><fn fn-type="COI-statement" id="conf8"><p>Vanni Bucci: Has received support from Vedanta Biosciences, Inc. under research agreement with his institution</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Supervision, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Validation, Investigation</p></fn><fn fn-type="con" id="con3"><p>Data curation, Validation, Investigation</p></fn><fn fn-type="con" id="con4"><p>Formal analysis</p></fn><fn fn-type="con" id="con5"><p>Conceptualization</p></fn><fn fn-type="con" id="con6"><p>Formal analysis</p></fn><fn fn-type="con" id="con7"><p>Formal analysis</p></fn><fn fn-type="con" id="con8"><p>Formal analysis</p></fn><fn fn-type="con" id="con9"><p>Formal analysis</p></fn><fn fn-type="con" id="con10"><p>Conceptualization</p></fn><fn fn-type="con" id="con11"><p>Conceptualization</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Formal analysis</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Data curation, Software, Formal analysis, Supervision, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: 11-strain time-series mouse experiments were performed under ethical approval by RIKEN, Keio and Azabu Universities under protocol H24-9(14) (RIKEN). 4-strain validation mouse work was performed at Brigham and Women's Hospital in Boston, MA in the Massachusetts Host Microbiome Center under IACUC protocol 2016N000141.</p></fn></fn-group></sec><sec id="s5" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.30916.012</object-id><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-30916-transrepform-v2.pdf"/></supplementary-material><sec id="s7" sec-type="datasets"><title>Major datasets</title><p>The following previously published dataset was used:</p><p><related-object content-type="generated-dataset" id="dataset1" source-id="http://trace.ddbj.nig.ac.jp/DRASearch/submission?acc=DRA003884" source-id-type="uri"><collab collab-type="author">Atarashi K</collab><collab collab-type="author">Tanoue T</collab><collab collab-type="author">Ando M</collab><collab collab-type="author">Kamada N</collab><collab collab-type="author">Nagano Y</collab><collab collab-type="author">Narushima S</collab><collab collab-type="author">Suda W</collab><collab collab-type="author">Imaoka A</collab><collab collab-type="author">Setoyama H</collab><collab collab-type="author">Nagamori T</collab><year>2015</year><source>Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells</source><ext-link ext-link-type="uri" xlink:href="http://trace.ddbj.nig.ac.jp/DRASearch/submission?acc=DRA003884">http://trace.ddbj.nig.ac.jp/DRASearch/submission?acc=DRA003884</ext-link><comment>Publicly available at the DDBJ Center (accession no. DRA003884)</comment></related-object></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arpaia</surname> <given-names>N</given-names></name><name><surname>Campbell</surname> <given-names>C</given-names></name><name><surname>Fan</surname> <given-names>X</given-names></name><name><surname>Dikiy</surname> <given-names>S</given-names></name><name><surname>van der Veeken</surname> <given-names>J</given-names></name><name><surname>deRoos</surname> <given-names>P</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Cross</surname> <given-names>JR</given-names></name><name><surname>Pfeffer</surname> <given-names>K</given-names></name><name><surname>Coffer</surname> <given-names>PJ</given-names></name><name><surname>Rudensky</surname> <given-names>AY</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation</article-title><source>Nature</source><volume>504</volume><fpage>451</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1038/nature12726</pub-id><pub-id pub-id-type="pmid">24226773</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atarashi</surname> <given-names>K</given-names></name><name><surname>Nishimura</surname> <given-names>J</given-names></name><name><surname>Shima</surname> <given-names>T</given-names></name><name><surname>Umesaki</surname> <given-names>Y</given-names></name><name><surname>Yamamoto</surname> <given-names>M</given-names></name><name><surname>Onoue</surname> <given-names>M</given-names></name><name><surname>Yagita</surname> <given-names>H</given-names></name><name><surname>Ishii</surname> <given-names>N</given-names></name><name><surname>Evans</surname> <given-names>R</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name><name><surname>Takeda</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>ATP drives lamina propria T(H)17 cell differentiation</article-title><source>Nature</source><volume>455</volume><fpage>808</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1038/nature07240</pub-id><pub-id pub-id-type="pmid">18716618</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atarashi</surname> <given-names>K</given-names></name><name><surname>Suda</surname> <given-names>W</given-names></name><name><surname>Luo</surname> <given-names>C</given-names></name><name><surname>Kawaguchi</surname> <given-names>T</given-names></name><name><surname>Motoo</surname> <given-names>I</given-names></name><name><surname>Narushima</surname> <given-names>S</given-names></name><name><surname>Kiguchi</surname> <given-names>Y</given-names></name><name><surname>Yasuma</surname> <given-names>K</given-names></name><name><surname>Watanabe</surname> <given-names>E</given-names></name><name><surname>Tanoue</surname> <given-names>T</given-names></name><name><surname>Thaiss</surname> <given-names>CA</given-names></name><name><surname>Sato</surname> <given-names>M</given-names></name><name><surname>Toyooka</surname> <given-names>K</given-names></name><name><surname>Said</surname> <given-names>HS</given-names></name><name><surname>Yamagami</surname> <given-names>H</given-names></name><name><surname>Rice</surname> <given-names>SA</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Johnson</surname> <given-names>RC</given-names></name><name><surname>Segre</surname> <given-names>JA</given-names></name><name><surname>Chen</surname> <given-names>K</given-names></name><name><surname>Kolls</surname> <given-names>JK</given-names></name><name><surname>Elinav</surname> <given-names>E</given-names></name><name><surname>Morita</surname> <given-names>H</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Hattori</surname> <given-names>M</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Ectopic colonization of oral bacteria in the intestine drives T<sub>H</sub>1 cell induction and inflammation</article-title><source>Science</source><volume>358</volume><fpage>359</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1126/science.aan4526</pub-id><pub-id pub-id-type="pmid">29051379</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atarashi</surname> <given-names>K</given-names></name><name><surname>Tanoue</surname> <given-names>T</given-names></name><name><surname>Ando</surname> <given-names>M</given-names></name><name><surname>Kamada</surname> <given-names>N</given-names></name><name><surname>Nagano</surname> <given-names>Y</given-names></name><name><surname>Narushima</surname> <given-names>S</given-names></name><name><surname>Suda</surname> <given-names>W</given-names></name><name><surname>Imaoka</surname> <given-names>A</given-names></name><name><surname>Setoyama</surname> <given-names>H</given-names></name><name><surname>Nagamori</surname> <given-names>T</given-names></name><name><surname>Ishikawa</surname> <given-names>E</given-names></name><name><surname>Shima</surname> <given-names>T</given-names></name><name><surname>Hara</surname> <given-names>T</given-names></name><name><surname>Kado</surname> <given-names>S</given-names></name><name><surname>Jinnohara</surname> <given-names>T</given-names></name><name><surname>Ohno</surname> <given-names>H</given-names></name><name><surname>Kondo</surname> <given-names>T</given-names></name><name><surname>Toyooka</surname> <given-names>K</given-names></name><name><surname>Watanabe</surname> <given-names>E</given-names></name><name><surname>Yokoyama</surname> <given-names>S</given-names></name><name><surname>Tokoro</surname> <given-names>S</given-names></name><name><surname>Mori</surname> <given-names>H</given-names></name><name><surname>Noguchi</surname> <given-names>Y</given-names></name><name><surname>Morita</surname> <given-names>H</given-names></name><name><surname>Ivanov</surname> <given-names>II</given-names></name><name><surname>Sugiyama</surname> <given-names>T</given-names></name><name><surname>Nuñez</surname> <given-names>G</given-names></name><name><surname>Camp</surname> <given-names>JG</given-names></name><name><surname>Hattori</surname> <given-names>M</given-names></name><name><surname>Umesaki</surname> <given-names>Y</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Th17 cell induction by adhesion of microbes to intestinal epithelial Cells</article-title><source>Cell</source><volume>163</volume><fpage>367</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.08.058</pub-id><pub-id pub-id-type="pmid">26411289</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atarashi</surname> <given-names>K</given-names></name><name><surname>Tanoue</surname> <given-names>T</given-names></name><name><surname>Oshima</surname> <given-names>K</given-names></name><name><surname>Suda</surname> <given-names>W</given-names></name><name><surname>Nagano</surname> <given-names>Y</given-names></name><name><surname>Nishikawa</surname> <given-names>H</given-names></name><name><surname>Fukuda</surname> <given-names>S</given-names></name><name><surname>Saito</surname> <given-names>T</given-names></name><name><surname>Narushima</surname> <given-names>S</given-names></name><name><surname>Hase</surname> <given-names>K</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Fritz</surname> <given-names>JV</given-names></name><name><surname>Wilmes</surname> <given-names>P</given-names></name><name><surname>Ueha</surname> <given-names>S</given-names></name><name><surname>Matsushima</surname> <given-names>K</given-names></name><name><surname>Ohno</surname> <given-names>H</given-names></name><name><surname>Olle</surname> <given-names>B</given-names></name><name><surname>Sakaguchi</surname> <given-names>S</given-names></name><name><surname>Taniguchi</surname> <given-names>T</given-names></name><name><surname>Morita</surname> <given-names>H</given-names></name><name><surname>Hattori</surname> <given-names>M</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota</article-title><source>Nature</source><volume>500</volume><fpage>232</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1038/nature12331</pub-id><pub-id pub-id-type="pmid">23842501</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkaid</surname> <given-names>Y</given-names></name><name><surname>Hand</surname> <given-names>TW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Role of the microbiota in immunity and inflammation</article-title><source>Cell</source><volume>157</volume><fpage>121</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.03.011</pub-id><pub-id pub-id-type="pmid">24679531</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilate</surname> <given-names>AM</given-names></name><name><surname>Lafaille</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Induced CD4+Foxp3+ regulatory T cells in immune tolerance</article-title><source>Annual Review of Immunology</source><volume>30</volume><fpage>733</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-075043</pub-id><pub-id pub-id-type="pmid">22224762</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucci</surname> <given-names>V</given-names></name><name><surname>Tzen</surname> <given-names>B</given-names></name><name><surname>Li</surname> <given-names>N</given-names></name><name><surname>Simmons</surname> <given-names>M</given-names></name><name><surname>Tanoue</surname> <given-names>T</given-names></name><name><surname>Bogart</surname> <given-names>E</given-names></name><name><surname>Deng</surname> <given-names>L</given-names></name><name><surname>Yeliseyev</surname> <given-names>V</given-names></name><name><surname>Delaney</surname> <given-names>ML</given-names></name><name><surname>Liu</surname> <given-names>Q</given-names></name><name><surname>Olle</surname> <given-names>B</given-names></name><name><surname>Stein</surname> <given-names>RR</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name><name><surname>Bry</surname> <given-names>L</given-names></name><name><surname>Gerber</surname> <given-names>GK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MDSINE: microbial dynamical systems inference engine for microbiome time-series analyses</article-title><source>Genome Biology</source><volume>17</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1186/s13059-016-0980-6</pub-id><pub-id pub-id-type="pmid">27259475</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffie</surname> <given-names>CG</given-names></name><name><surname>Bucci</surname> <given-names>V</given-names></name><name><surname>Stein</surname> <given-names>RR</given-names></name><name><surname>McKenney</surname> <given-names>PT</given-names></name><name><surname>Ling</surname> <given-names>L</given-names></name><name><surname>Gobourne</surname> <given-names>A</given-names></name><name><surname>No</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>Kinnebrew</surname> <given-names>M</given-names></name><name><surname>Viale</surname> <given-names>A</given-names></name><name><surname>Littmann</surname> <given-names>E</given-names></name><name><surname>van den Brink</surname> <given-names>MR</given-names></name><name><surname>Jenq</surname> <given-names>RR</given-names></name><name><surname>Taur</surname> <given-names>Y</given-names></name><name><surname>Sander</surname> <given-names>C</given-names></name><name><surname>Cross</surname> <given-names>JR</given-names></name><name><surname>Toussaint</surname> <given-names>NC</given-names></name><name><surname>Xavier</surname> <given-names>JB</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile</article-title><source>Nature</source><volume>517</volume><fpage>205</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1038/nature13828</pub-id><pub-id pub-id-type="pmid">25337874</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>d’Onofrio</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences</article-title><source>Physica D: Nonlinear Phenomena</source><volume>208</volume><fpage>220</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1016/j.physd.2005.06.032</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donia</surname> <given-names>MS</given-names></name><name><surname>Fischbach</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Small molecules from the human microbiota</article-title><source>Science</source><volume>349</volume><elocation-id>1254766</elocation-id><pub-id pub-id-type="doi">10.1126/science.1254766</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faith</surname> <given-names>JJ</given-names></name><name><surname>Ahern</surname> <given-names>PP</given-names></name><name><surname>Ridaura</surname> <given-names>VK</given-names></name><name><surname>Cheng</surname> <given-names>J</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice</article-title><source>Science Translational Medicine</source><volume>6</volume><elocation-id>ra11</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3008051</pub-id><pub-id pub-id-type="pmid">24452263</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garber</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Drugging the gut microbiome</article-title><source>Nature Biotechnology</source><volume>33</volume><fpage>228</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1038/nbt.3161</pub-id><pub-id pub-id-type="pmid">25748907</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname> <given-names>WS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cancer and the microbiota</article-title><source>Science</source><volume>348</volume><fpage>80</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1126/science.aaa4972</pub-id><pub-id pub-id-type="pmid">25838377</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerber</surname> <given-names>GK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The dynamic microbiome</article-title><source>FEBS Letters</source><volume>588</volume><fpage>4131</fpage><lpage>4139</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2014.02.037</pub-id><pub-id pub-id-type="pmid">24583074</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geva-Zatorsky</surname> <given-names>N</given-names></name><name><surname>Sefik</surname> <given-names>E</given-names></name><name><surname>Kua</surname> <given-names>L</given-names></name><name><surname>Pasman</surname> <given-names>L</given-names></name><name><surname>Tan</surname> <given-names>TG</given-names></name><name><surname>Ortiz-Lopez</surname> <given-names>A</given-names></name><name><surname>Yanortsang</surname> <given-names>TB</given-names></name><name><surname>Yang</surname> <given-names>L</given-names></name><name><surname>Jupp</surname> <given-names>R</given-names></name><name><surname>Mathis</surname> <given-names>D</given-names></name><name><surname>Benoist</surname> <given-names>C</given-names></name><name><surname>Kasper</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mining the human gut microbiota for immunomodulatory organisms</article-title><source>Cell</source><volume>168</volume><fpage>928</fpage><lpage>943</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.01.022</pub-id><pub-id pub-id-type="pmid">28215708</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Kugathasan</surname> <given-names>S</given-names></name><name><surname>Denson</surname> <given-names>LA</given-names></name><name><surname>Vázquez-Baeza</surname> <given-names>Y</given-names></name><name><surname>Van Treuren</surname> <given-names>W</given-names></name><name><surname>Ren</surname> <given-names>B</given-names></name><name><surname>Schwager</surname> <given-names>E</given-names></name><name><surname>Knights</surname> <given-names>D</given-names></name><name><surname>Song</surname> <given-names>SJ</given-names></name><name><surname>Yassour</surname> <given-names>M</given-names></name><name><surname>Morgan</surname> <given-names>XC</given-names></name><name><surname>Kostic</surname> <given-names>AD</given-names></name><name><surname>Luo</surname> <given-names>C</given-names></name><name><surname>González</surname> <given-names>A</given-names></name><name><surname>McDonald</surname> <given-names>D</given-names></name><name><surname>Haberman</surname> <given-names>Y</given-names></name><name><surname>Walters</surname> <given-names>T</given-names></name><name><surname>Baker</surname> <given-names>S</given-names></name><name><surname>Rosh</surname> <given-names>J</given-names></name><name><surname>Stephens</surname> <given-names>M</given-names></name><name><surname>Heyman</surname> <given-names>M</given-names></name><name><surname>Markowitz</surname> <given-names>J</given-names></name><name><surname>Baldassano</surname> <given-names>R</given-names></name><name><surname>Griffiths</surname> <given-names>A</given-names></name><name><surname>Sylvester</surname> <given-names>F</given-names></name><name><surname>Mack</surname> <given-names>D</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Crandall</surname> <given-names>W</given-names></name><name><surname>Hyams</surname> <given-names>J</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The treatment-naive microbiome in new-onset Crohn's disease</article-title><source>Cell Host &amp; Microbe</source><volume>15</volume><fpage>382</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2014.02.005</pub-id><pub-id pub-id-type="pmid">24629344</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname> <given-names>JJ</given-names></name><name><surname>Sartor</surname> <given-names>RB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Therapeutic manipulation of the microbiome in IBD: Current results and future approaches</article-title><source>Current Treatment Options in Gastroenterology</source><volume>13</volume><fpage>105</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1007/s11938-014-0042-7</pub-id><pub-id pub-id-type="pmid">25595930</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hofbauer</surname> <given-names>J</given-names></name><name><surname>Sigmund</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1998">1998</year><source>Evolutionary Games and Population Dynamics</source><publisher-name>Cambridge University Press</publisher-name></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname> <given-names>K</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The microbiome in infectious disease and inflammation</article-title><source>Annual Review of Immunology</source><volume>30</volume><fpage>759</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-074937</pub-id><pub-id pub-id-type="pmid">22224764</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname> <given-names>II</given-names></name><name><surname>Atarashi</surname> <given-names>K</given-names></name><name><surname>Manel</surname> <given-names>N</given-names></name><name><surname>Brodie</surname> <given-names>EL</given-names></name><name><surname>Shima</surname> <given-names>T</given-names></name><name><surname>Karaoz</surname> <given-names>U</given-names></name><name><surname>Wei</surname> <given-names>D</given-names></name><name><surname>Goldfarb</surname> <given-names>KC</given-names></name><name><surname>Santee</surname> <given-names>CA</given-names></name><name><surname>Lynch</surname> <given-names>SV</given-names></name><name><surname>Tanoue</surname> <given-names>T</given-names></name><name><surname>Imaoka</surname> <given-names>A</given-names></name><name><surname>Itoh</surname> <given-names>K</given-names></name><name><surname>Takeda</surname> <given-names>K</given-names></name><name><surname>Umesaki</surname> <given-names>Y</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name><name><surname>Littman</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Induction of intestinal Th17 cells by segmented filamentous bacteria</article-title><source>Cell</source><volume>139</volume><fpage>485</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.09.033</pub-id><pub-id pub-id-type="pmid">19836068</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maldonado-Gómez</surname> <given-names>MX</given-names></name><name><surname>Martínez</surname> <given-names>I</given-names></name><name><surname>Bottacini</surname> <given-names>F</given-names></name><name><surname>O'Callaghan</surname> <given-names>A</given-names></name><name><surname>Ventura</surname> <given-names>M</given-names></name><name><surname>van Sinderen</surname> <given-names>D</given-names></name><name><surname>Hillmann</surname> <given-names>B</given-names></name><name><surname>Vangay</surname> <given-names>P</given-names></name><name><surname>Knights</surname> <given-names>D</given-names></name><name><surname>Hutkins</surname> <given-names>RW</given-names></name><name><surname>Walter</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Stable engraftment of bifidobacterium longum ah1206 in the human gut depends on individualized features of the resident microbiome</article-title><source>Cell Host &amp; Microbe</source><volume>20</volume><fpage>515</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2016.09.001</pub-id><pub-id pub-id-type="pmid">27693307</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michor</surname> <given-names>F</given-names></name><name><surname>Beal</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Improving cancer treatment via mathematical modeling: surmounting the challenges is worth the effort</article-title><source>Cell</source><volume>163</volume><fpage>1059</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.11.002</pub-id><pub-id pub-id-type="pmid">26590416</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname> <given-names>XC</given-names></name><name><surname>Kabakchiev</surname> <given-names>B</given-names></name><name><surname>Waldron</surname> <given-names>L</given-names></name><name><surname>Tyler</surname> <given-names>AD</given-names></name><name><surname>Tickle</surname> <given-names>TL</given-names></name><name><surname>Milgrom</surname> <given-names>R</given-names></name><name><surname>Stempak</surname> <given-names>JM</given-names></name><name><surname>Gevers</surname> <given-names>D</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name><name><surname>Silverberg</surname> <given-names>MS</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease</article-title><source>Genome Biology</source><volume>16</volume><elocation-id>67</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-015-0637-x</pub-id><pub-id pub-id-type="pmid">25887922</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narushima</surname> <given-names>S</given-names></name><name><surname>Sugiura</surname> <given-names>Y</given-names></name><name><surname>Oshima</surname> <given-names>K</given-names></name><name><surname>Atarashi</surname> <given-names>K</given-names></name><name><surname>Hattori</surname> <given-names>M</given-names></name><name><surname>Suematsu</surname> <given-names>M</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Characterization of the 17 strains of regulatory T cell-inducing human-derived Clostridia</article-title><source>Gut Microbes</source><volume>5</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.4161/gmic.28572</pub-id><pub-id pub-id-type="pmid">24642476</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olle</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Medicines from microbiota</article-title><source>Nature Biotechnology</source><volume>31</volume><fpage>309</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1038/nbt.2548</pub-id><pub-id pub-id-type="pmid">23563425</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omenetti</surname> <given-names>S</given-names></name><name><surname>Pizarro</surname> <given-names>TT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The Treg/Th17 Axis: a dynamic balance regulated by the gut microbiome</article-title><source>Frontiers in Immunology</source><volume>6</volume><pub-id pub-id-type="doi">10.3389/fimmu.2015.00639</pub-id><pub-id pub-id-type="pmid">26734006</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paun</surname> <given-names>A</given-names></name><name><surname>Yau</surname> <given-names>C</given-names></name><name><surname>Danska</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Immune recognition and response to the intestinal microbiome in type 1 diabetes</article-title><source>Journal of Autoimmunity</source><volume>71</volume><fpage>10</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.jaut.2016.02.004</pub-id><pub-id pub-id-type="pmid">26908163</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Round</surname> <given-names>JL</given-names></name><name><surname>Mazmanian</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota</article-title><source>PNAS</source><volume>107</volume><fpage>12204</fpage><lpage>12209</lpage><pub-id pub-id-type="doi">10.1073/pnas.0909122107</pub-id><pub-id pub-id-type="pmid">20566854</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudensky</surname> <given-names>AY</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Regulatory T cells and Foxp3</article-title><source>Immunological Reviews</source><volume>241</volume><fpage>260</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1111/j.1600-065X.2011.01018.x</pub-id><pub-id pub-id-type="pmid">21488902</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schirmer</surname> <given-names>M</given-names></name><name><surname>Smeekens</surname> <given-names>SP</given-names></name><name><surname>Vlamakis</surname> <given-names>H</given-names></name><name><surname>Jaeger</surname> <given-names>M</given-names></name><name><surname>Oosting</surname> <given-names>M</given-names></name><name><surname>Franzosa</surname> <given-names>EA</given-names></name><name><surname>Ter Horst</surname> <given-names>R</given-names></name><name><surname>Jansen</surname> <given-names>T</given-names></name><name><surname>Jacobs</surname> <given-names>L</given-names></name><name><surname>Bonder</surname> <given-names>MJ</given-names></name><name><surname>Kurilshikov</surname> <given-names>A</given-names></name><name><surname>Fu</surname> <given-names>J</given-names></name><name><surname>Joosten</surname> <given-names>LAB</given-names></name><name><surname>Zhernakova</surname> <given-names>A</given-names></name><name><surname>Huttenhower</surname> <given-names>C</given-names></name><name><surname>Wijmenga</surname> <given-names>C</given-names></name><name><surname>Netea</surname> <given-names>MG</given-names></name><name><surname>Xavier</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Linking the human gut microbiome to inflammatory cytokine production capacity</article-title><source>Cell</source><volume>167</volume><fpage>1125</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.020</pub-id><pub-id pub-id-type="pmid">27814509</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>PM</given-names></name><name><surname>Howitt</surname> <given-names>MR</given-names></name><name><surname>Panikov</surname> <given-names>N</given-names></name><name><surname>Michaud</surname> <given-names>M</given-names></name><name><surname>Gallini</surname> <given-names>CA</given-names></name><name><surname>Bohlooly-Y</surname> <given-names>M</given-names></name><name><surname>Glickman</surname> <given-names>JN</given-names></name><name><surname>Garrett</surname> <given-names>WS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis</article-title><source>Science</source><volume>341</volume><fpage>569</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1126/science.1241165</pub-id><pub-id pub-id-type="pmid">23828891</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smits</surname> <given-names>SA</given-names></name><name><surname>Marcobal</surname> <given-names>A</given-names></name><name><surname>Higginbottom</surname> <given-names>S</given-names></name><name><surname>Sonnenburg</surname> <given-names>JL</given-names></name><name><surname>Kashyap</surname> <given-names>PC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Individualized Responses of Gut Microbiota to Dietary Intervention Modeled in Humanized Mice</article-title><source>mSystems</source><volume>1</volume><elocation-id>e00098-16</elocation-id><pub-id pub-id-type="doi">10.1128/mSystems.00098-16</pub-id><pub-id pub-id-type="pmid">27822551</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname> <given-names>RR</given-names></name><name><surname>Bucci</surname> <given-names>V</given-names></name><name><surname>Toussaint</surname> <given-names>NC</given-names></name><name><surname>Buffie</surname> <given-names>CG</given-names></name><name><surname>Rätsch</surname> <given-names>G</given-names></name><name><surname>Pamer</surname> <given-names>EG</given-names></name><name><surname>Sander</surname> <given-names>C</given-names></name><name><surname>Xavier</surname> <given-names>JB</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiota</article-title><source>PLoS Computational Biology</source><volume>9</volume><elocation-id>e1003388</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003388</pub-id><pub-id pub-id-type="pmid">24348232</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surana</surname> <given-names>NK</given-names></name><name><surname>Kasper</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Moving beyond microbiome-wide associations to causal microbe identification</article-title><source>Nature</source><volume>552</volume><fpage>244</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1038/nature25019</pub-id><pub-id pub-id-type="pmid">29211710</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanoue</surname> <given-names>T</given-names></name><name><surname>Atarashi</surname> <given-names>K</given-names></name><name><surname>Honda</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Development and maintenance of intestinal regulatory T cells</article-title><source>Nature Reviews Immunology</source><volume>16</volume><fpage>295</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1038/nri.2016.36</pub-id><pub-id pub-id-type="pmid">27087661</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Nood</surname> <given-names>E</given-names></name><name><surname>Vrieze</surname> <given-names>A</given-names></name><name><surname>Nieuwdorp</surname> <given-names>M</given-names></name><name><surname>Fuentes</surname> <given-names>S</given-names></name><name><surname>Zoetendal</surname> <given-names>EG</given-names></name><name><surname>de Vos</surname> <given-names>WM</given-names></name><name><surname>Visser</surname> <given-names>CE</given-names></name><name><surname>Kuijper</surname> <given-names>EJ</given-names></name><name><surname>Bartelsman</surname> <given-names>JF</given-names></name><name><surname>Tijssen</surname> <given-names>JG</given-names></name><name><surname>Speelman</surname> <given-names>P</given-names></name><name><surname>Dijkgraaf</surname> <given-names>MG</given-names></name><name><surname>Keller</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Duodenal infusion of donor feces for recurrent Clostridium difficile</article-title><source>New England Journal of Medicine</source><volume>368</volume><fpage>407</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1205037</pub-id><pub-id pub-id-type="pmid">23323867</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname> <given-names>AT</given-names></name><name><surname>Fukumori</surname> <given-names>C</given-names></name><name><surname>Ferreira</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases</article-title><source>Clinical &amp; Translational Immunology</source><volume>5</volume><elocation-id>e87</elocation-id><pub-id pub-id-type="doi">10.1038/cti.2016.38</pub-id><pub-id pub-id-type="pmid">27757227</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vrieze</surname> <given-names>A</given-names></name><name><surname>Van Nood</surname> <given-names>E</given-names></name><name><surname>Holleman</surname> <given-names>F</given-names></name><name><surname>Salojärvi</surname> <given-names>J</given-names></name><name><surname>Kootte</surname> <given-names>RS</given-names></name><name><surname>Bartelsman</surname> <given-names>JF</given-names></name><name><surname>Dallinga-Thie</surname> <given-names>GM</given-names></name><name><surname>Ackermans</surname> <given-names>MT</given-names></name><name><surname>Serlie</surname> <given-names>MJ</given-names></name><name><surname>Oozeer</surname> <given-names>R</given-names></name><name><surname>Derrien</surname> <given-names>M</given-names></name><name><surname>Druesne</surname> <given-names>A</given-names></name><name><surname>Van Hylckama Vlieg</surname> <given-names>JE</given-names></name><name><surname>Bloks</surname> <given-names>VW</given-names></name><name><surname>Groen</surname> <given-names>AK</given-names></name><name><surname>Heilig</surname> <given-names>HG</given-names></name><name><surname>Zoetendal</surname> <given-names>EG</given-names></name><name><surname>Stroes</surname> <given-names>ES</given-names></name><name><surname>de Vos</surname> <given-names>WM</given-names></name><name><surname>Hoekstra</surname> <given-names>JB</given-names></name><name><surname>Nieuwdorp</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome</article-title><source>Gastroenterology</source><volume>143</volume><fpage>913</fpage><lpage>916</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2012.06.031</pub-id><pub-id pub-id-type="pmid">22728514</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wangersky</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>Lotka-volterra population models</article-title><source>Annual Review of Ecology and Systematics</source><volume>9</volume><fpage>189</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1146/annurev.es.09.110178.001201</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weil</surname> <given-names>AA</given-names></name><name><surname>Hohmann</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fecal microbiota transplant: benefits and risks</article-title><source>Open Forum Infectious Diseases</source><volume>2</volume><fpage>ofv005</fpage><pub-id pub-id-type="doi">10.1093/ofid/ofv005</pub-id><pub-id pub-id-type="pmid">26034756</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.30916.016</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Knight</surname><given-names>Rob</given-names></name><role>Reviewing Editor</role><aff id="aff15"><institution>University of California, San Diego</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Computational prediction of immune effectors from the microbiome to select for optimal immune–modulating consortia&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Wendy Garrett as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>In this manuscript, the authors colonize germ–free mice with individual bacterial strains, and test for induction of T<sub>regs</sub>. They then use this information to construct a model for induction of T<sub>regs</sub> by a complex microbial community, reducing the number of combinations that must be tested explicitly. Specifically, they predict strong– and weak–inducing consortia and provide experimental validation of fit to the model. The authors use existing qPCR data from 13 strains and a generalized Lotka–Volterra model they previously published as the basis for the experimental validation. They deploy this model on 11–strain and 4–strain consortia. The three 11–strain combinations consist of two that lack strains with the highest &quot;keystone&quot; scores, and one that lacks the strain with the lowest score. They also test five 4–strain consortia, again collecting information on the dynamics. They also provide additional predictions relevant to ulcerative colitis.</p><p>In our view, this manuscript provides a fascinating example of validation of computational predictions relating specific microbial strains to immune response. However, we believe that although the work is impressive, additional validation needs to be done and that the last disease test case is less convincing than the rest of the work. We recommend that this be either removed or that experimental validation be provided.</p><p>Overall this is an impressive body of work and, as the authors note, point the way towards better rational design of microbial communities that alter the immune system.</p><p>Essential revisions:</p><p>1) Several of the figures are misleading or unreadable. Figure 3 shows observed vs predicted data and r<sup>2</sup> in log space, but the results are likely to look much worse in linear space given the pattern of scatter, and this should be disclosed to readers rather than concealed.</p><p>2) Figure 4B is unreadable, and per–strain correlations should be summarized in a different way that is easier to understand.</p><p>3) Figure 5A is also unreadable and it is impossible to match up the stacked bar and area presentation; some other form of showing the data is needed.</p><p>4) Because the pathway data are normalized, Mann–Whitney U is not appropriate (in related tasks, its false discovery rate has been shown to be up to 95%) and appropriate statistics for differential abundance that take compositionality into account should be used.</p><p>5) The theoretical predictions for the consortia transferred into mice with UC patient stool, while intriguing, should ideally be backed by experiment. The results showing model fit to data for the 4–strain communities are impressive but much weaker than the rhetoric in the text implies: Spearman rho of –0.47 means that more than three quarters of the variance in the rank order of the data, let alone the quantitative data, is not explained by their explanatory variable. So, although the association is statistically significant, its power to predict results is low. This component should be removed.</p><p>6) The authors have only moderate support for their primary hypothesis: that immune response as a function of microbial consortia can be predicted via a model. In the GF mouse case, I see the key data testing this hypothesis in Figure 4E. While the stated correlation is significant, I'm concerned this statistic is being used inappropriately. Incorporating the replicates into the correlation seems ill–advised (doing so, for example, could let you compute a correlation involving only two groups provided each had enough replicates within). Rather, if the authors want to use the replicates, an ANOVA with post–hoc tests seems more appropriate. Perhaps even better, the authors could correlate the mean observed percentage of CD4<sup>+</sup>FOXP3<sup>+</sup> to the mean predicted TrIS across the 5 groups. The trends look promising. But, this may be too small a number of groups to actually power such a correlation; hence, my overall concern that there's not enough data validating the model.</p><p>7) The manuscript needs to make clear when the authors are using new vs. previously published, and in silico vs. measured data. Examples include Figure 4, which analyses the in-silico results using a mixture of metabolomic predictions and experimental validation. It seems Figure 1 and Figure 2 are efforts to clear up that confusion. Unfortunately, they didn't work in my case; perhaps it’s worth trying to merge those figures into a single flow chart?</p><p>8) Some variables in Equations 1–3 aren't explicitly defined in the text (and don't seem to be in the Materials and methods section either), including i, α, β, ε, and n. These need to be defined.</p><p>9) How many strains were available and how many strains were actually selected? The numbers mentioned in the text are inconsistent in different parts. I provide only a few examples below, but this inconsistency is present throughout the text.</p><p>– Introduction: &quot;a mixture of 17 human–derived Clostridia (ref 9)&quot;.</p><p>– Introduction: &quot;our previous work identified on the order of 15 possible candidate strains to select from (ref 9)&quot;.</p><p>– Results section: &quot;we gavaged 14 mice with one of three possible 11–strain subsets from the original 13 strains (Figure 2)&quot;.</p><p>– Figure 1: &quot;12 therapeutically relevant Clostridia strains in the lumen&quot;.</p><p>– Figure 2: &quot;13 strain cocktail&quot;.</p><p>Bottom line, the authors should provide a clear layout/table of the strains that were identified in ref 9, of the strains that were used in the paper, and of the combinations. At the moment, this part is very confusing, and the numbers do not match throughout the text.</p><p>10) How many GF mice were actually used, and why do the authors use IQI GF mice for some experiments, and C57BL/6 GF mice for others? The mouse genetic background was changed for no apparent reason.</p><p>Also Introduction: &quot;we gavaged 14 mice with one of three possible 11–strain subsets from the original 13 strains (Figure 2)&quot;.</p><p>Materials and methods section: &quot;the three mixtures of 11 strains (described above) were orally inoculated into five IQI germ–free adult mice each.&quot;</p><p>How many mice were actually gavages with the 11 strains? 14 or 5? Please clarify the experimental design.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.30916.017</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Several of the figures are misleading or unreadable. Figure 3 shows observed vs predicted data and r<sup>2</sup> in log space, but the results are likely to look much worse in linear space given the pattern of scatter, and this should be disclosed to readers rather than concealed.</p></disp-quote><p>We edited Figure 3 by removing the old scatter plot (old panel B) and substituted it with one where we calculated the Spearman correlation between observations and predictions at different discrete time points in order to not violate the assumption of independence of observations for correlation tests. Calculation of Spearman’s correlation between predictions and observations follows our previous work (Stein et al., 2013). See also subsection “Generation of multimodal microbiome–T<sub>reg</sub> data”.</p><disp-quote content-type="editor-comment"><p>2) Figure 4B is unreadable, and per–strain correlations should be summarized in a different way that is easier to understand.</p></disp-quote><p>We agree with the reviewer’s comment. Accordingly, we modified Figure 4B to only focus on Strain 27. We added a new supplementary figure (Figure 4—figure supplement 1) to display the same analysis for all other strains each in a separate panel.</p><disp-quote content-type="editor-comment"><p>3) Figure 5A is also unreadable and it is impossible to match up the stacked bar and area presentation; some other form of showing the data is needed</p></disp-quote><p>Following the suggestion from the editor we removed the UC biota analysis. Hence, Figure 5 is now removed from the manuscript.</p><disp-quote content-type="editor-comment"><p>4) Because the pathway data are normalized, Mann–Whitney U is not appropriate (in related tasks, its false discovery rate has been shown to be up to 95%) and appropriate statistics for differential abundance that take compositionality into account should be used.</p></disp-quote><p>We agree with the reviewer’s comment. Similarly to the response to comment #3, this analysis is not anymore included as the UC-biota related work has been removed from the manuscript.</p><disp-quote content-type="editor-comment"><p>5) The theoretical predictions for the consortia transferred into mice with UC patient stool, while intriguing, should ideally be backed by experiment. The results showing model fit to data for the 4–strain communities are impressive but much weaker than the rhetoric in the text implies: Spearman rho of –0.47 means that more than three quarters of the variance in the rank order of the data, let alone the quantitative data, is not explained by their explanatory variable. So, although the association is statistically significant, its power to predict results is low. This component should be removed.</p></disp-quote><p>As suggested by the editor, we removed the data and analysis pertaining the UC biota scenario. Regarding the analysis of the 4–strain validation experiments see the response to comment #6.</p><disp-quote content-type="editor-comment"><p>6) The authors have only moderate support for their primary hypothesis: that immune response as a function of microbial consortia can be predicted via a model. In the GF mouse case, I see the key data testing this hypothesis in Figure 4E. While the stated correlation is significant, I'm concerned this statistic is being used inappropriately. Incorporating the replicates into the correlation seems ill–advised (doing so, for example, could let you compute a correlation involving only two groups provided each had enough replicates within). Rather, if the authors want to use the replicates, an ANOVA with post–hoc tests seems more appropriate. Perhaps even better, the authors could correlate the mean observed percentage of CD4<sup>+</sup>FOXP3<sup>+</sup> to the mean predicted TrIS across the 5 groups. The trends look promising. But, this may be too small a number of groups to actually power such a correlation; hence, my overall concern that there's not enough data validating the model.</p></disp-quote><p>We fully agree with the reviewer’s comment and followed the reviewer’s suggestion to correlate the mean CD4<sup>+</sup>FOXP3<sup>+</sup> Treg level for each consortium with the modeling-predicted Treg induction score. Pearson’s correlation yields a coefficient of 0.97 and a p-value &lt; 0.01. This should sufficiently validate our modeling predictions. We accordingly modified the text (see subsection “Derivation of the Treg Induction Score (TrIS) and selection of T<sub>reg</sub>-inducing consortia”), the related figure panel and the corresponding caption.</p><disp-quote content-type="editor-comment"><p>7) The manuscript needs to make clear when the authors are using new vs. previously published, and in silico vs. measured data. Examples include Figure 4, which analyses the in-silico results using a mixture of metabolomic predictions and experimental validation. It seems Figure 1 and Figure 2 are efforts to clear up that confusion. Unfortunately, they didn't work in my case; perhaps it’s worth trying to merge those figures into a single flow chart?</p></disp-quote><p>We agree with the reviewer and apologize for the confusion. We edited Figure 1 to be solely a clear conceptual diagram detailing the entire workflow that we present in the paper. We also rearranged Figure 2 and explicitly state what is new data and what data was published already. Also, we now explicitly specify (in Figure 2 and caption) what data was experimentally measured and what was derived from in silico simulations. We also better describe this in the main text (see Introduction and Results section). See also response to comment #9.</p><disp-quote content-type="editor-comment"><p>8) Some variables in Equations 1–3 aren't explicitly defined in the text (and don't seem to be in the Materials and methods section either), including i, α, β, ε, and n. These need to be defined.</p></disp-quote><p>Following the reviewer’s suggestion, we included a detailed description of the used parameters when they are introduced (see subsection “Derivation of the microbiome–T<sub>reg</sub> mathematical model to select microbial consortia” and Discussion section).</p><disp-quote content-type="editor-comment"><p>9) How many strains were available and how many strains were actually selected? The numbers mentioned in the text are inconsistent in different parts. I provide only a few examples below, but this inconsistency is present throughout the text.</p><p>– Introduction: &quot;a mixture of 17 human–derived Clostridia (ref 9)&quot;.</p><p>– Introduction: &quot;our previous work identified on the order of 15 possible candidate strains to select from (ref 9)&quot;.</p><p>– Results section: &quot;we gavaged 14 mice with one of three possible 11–strain subsets from the original 13 strains (Figure 2)&quot;.</p><p>– Figure 1: &quot;12 therapeutically relevant Clostridia strains in the lumen&quot;.</p><p>– Figure 2: &quot;13 strain cocktail&quot;.</p><p>Bottom line, the authors should provide a clear layout/table of the strains that were identified in ref 9, of the strains that were used in the paper, and of the combinations. At the moment, this part is very confusing, and the numbers do not match throughout the text.</p></disp-quote><p>We agree with the reviewer comment and again apologize for the confusion. Following the reviewers comment we made a table (Table 1) detailing membership for all the experiments performed for this work as well as from our previous studies. We also modified the text to clarify this point (Introduction).</p><disp-quote content-type="editor-comment"><p>10) How many GF mice were actually used, and why do the authors use IQI GF mice for some experiments, and C57BL/6 GF mice for others? The mouse genetic background was changed for no apparent reason.</p><p>Also Introduction: &quot;we gavaged 14 mice with one of three possible 11–strain subsets from the original 13 strains (Figure 2)&quot;.</p><p>Materials and methods section: &quot;the three mixtures of 11 strains (described above) were orally inoculated into five IQI germ–free adult mice each.&quot;</p><p>How many mice were actually gavages with the 11 strains? 14 or 5? Please clarify the experimental design.</p></disp-quote><p>We made consistent and clarified in throughout text the number of animals used. The use of a C57BL/6 background for these experiments was motivated by animal availability at the time of performing experimental validation. C57BL/6 use can be justified by the fact that previous work from us has shown that Treg induction by our Clostridia strains does not differ between Balb/c, IQI, and C57BL/6 mice (see Atarashi et al., 2015). We reworded the text and this statement and added a paragraph to the Discussion section.</p></body></sub-article></article>